Evaluation of Hepatoprotective and Antioxidant Effect of Girardenia Zeylanica Dcne Leaf Extract Against Ccl4 Induced Liver Damage in Rats by Monisha, R
EVALUATION OF HEPATOPROTECTIVE AND
ANTIOXIDANT EFFECT OF GIRARDENIA ZEYLANICA DCNE
LEAF EXTRACT AGAINST CCl4 INDUCED LIVER DAMAGE IN
RATS 
Dissertation submitted to
THE TAMILNADU DR. M.G.R.MEDICAL UNIVERSITY
CHENNAI – 32
In Partial fulfillment of the requirements for the award of the Degree of
MASTER OF PHARMACY
IN
PHARMACOLOGY
Submitted by:
Reg. No: 26116596
Under The Guidance Of
Mr. G. SEKAR M.Pharm.,
Assistant Professor
DEPARTMENT OF PHARMACOLOGY
J. K. K. MUNIRAJAH MEDICAL RESEARCH FOUNDATION
COLLEGE OF PHARMACY, B. KOMARAPALAYAM
TAMILNADU
APRIL 2014
Mr. G. SEKAR M.Pharm.,
Asst. Professor, Department of Pharmacology
J.K.K. Munirajah Medical Research Foundation,
College of Pharmacy
B.Komarapalayam. Namakkal – 638 183. 
CERTIFICATE
  This  is  to  certify  that  the  dissertation  work  entitled  “EVALUATION  OF
HEPATOPROTECTIVE  AND  ANTIOXIDANT  EFFECT  OF   GIRARDENIA
ZEYLANICA  DCNE LEAF  EXTRACT  AGAINST CCl4 INDUCED  LIVER
DAMAGE IN RATS” submitted to The Tamilnadu Dr. M.G.R. Medical University,
Chennai, is a bonafide work, which was carried out by Mrs. MONISHA. R. (Reg. No.
26116596) for the partial fulfillment for the degree of MASTER OF PHARMACY in
Pharmacology under my guidance during the academic year 2013-2014.
Mr. G. SEKAR. M.Pharm.,
Assistant Professor,
Department of Pharmacology.
Date :
Place: Komarapalayam
Mr. V. SURESH M.Pharm.,  (Ph.D.),
Asst. Professor and Head Dept. of Pharmacology
J.K.K. Munirajah Medical Research Foundation,
College of Pharmacy
B.Komarapalayam. Namakkal – 638 183. 
CERTIFICATE
This  is  to  certify  that  the  dissertation  work  entitled  “EVALUATION  OF
HEPATOPROTECTIVE  AND  ANTIOXIDANT  EFFECT  OF  GIRARDENIA
ZEYLANICA  DCNE LEAF  EXTRACT  AGAINST CCl4 INDUCED  LIVER
DAMAGE IN RATS” submitted to The Tamilnadu Dr. M.G.R. Medical University,
Chennai, is a bonafide work, which was carried out by Mrs. MONISHA. R. (Reg. No.
26116596) for the partial fulfillment for the degree of MASTER OF PHARMACY in
Pharmacology  under  the  supervision  of  Mr.  G.  SEKAR,  Assistant  Professor,
Department of Pharmacology during the academic year 2013-2014.
Mr.V. SURESH M.Pharm., (Ph.D.),
Assistant Professor,
Department of Pharmacology.
Date :
Place: Komarapalayam
Dr.N. SENTHIL KUMAR, M.Pharm., Ph.D,
Principal,
J.K.K. Munirajah Medical Research Foundation,
College of Pharmacy,
Komarapalayam.
CERTIFICATE
This  is  to  certify  that  the  dissertation  work  entitled  “EVALUATION  OF
HEPATOPROTECTIVE  AND  ANTIOXIDANT  EFFECT  OF  GIRARDENIA
ZEYLANICA  DCNE LEAF  EXTRACT  AGAINST CCl4 INDUCED  LIVER
DAMAGE IN RATS” submitted to The Tamilnadu Dr. M.G.R. Medical University,
Chennai, is a bonafide work, which was carried out by Mrs. MONISHA. R. (Reg. No.
26116596) for the partial fulfillment for the degree of MASTER OF PHARMACY in
Pharmacology  under  the  supervision  of  Mr.  G.  SEKAR,  Assistant  Professor,
Department of Pharmacology during the academic year 2013-2014.
Dr.N.SENTHIL KUMAR, M.Pharm., Ph.D,
Principal.
Date :
Place: Komarapalayam
DECLARATION
I  hereby  declare  that  this  dissertation  entitled  “EVALUATION  OF
HEPATOPROTECTIVE AND ANTIOXIDANT EFFECT OF  GIRARDENIA
ZEYLANICA  DCNE LEAF  EXTRACT  AGAINST CCl4 INDUCED  LIVER
DAMAGE IN RATS” is based on the original work carried out by me under the
guidance  and  supervision  of  Mr.  G.  SEKAR,  M.Pharm.,  Asst  Professor,
Department of Pharmacology for submission to the Tamilnadu Dr. M.G.R. Medical
University,  Chennai  in  partial  fulfillment  for  the  degree  of  MASTER  OF
PHARMACY in Pharmacology.  This work is original and has not been submitted
in part or full for the award of any other degree or diploma of any other university.
The  information  furnished  in  this  dissertation  is  genuine  to  the  best  of  my
knowledge and belief.  
Mrs. MONISHA. R. 
Reg. No: 26116596
Date:
Place: Komarapalayam
ACKNOWLEDGMENT
The expressivity of words looses significance when research for an appealing
sentence  of  gratitude  and  obligation,  since  acknowledgement  is  the only part  of
dissertation which lacks “guidance”. During my journey from objective to goal, I
have experienced shower of blessings from my great god. I offered with flower of
blessings from the almighty, which has been the source of Strength throughout my
life.
First  and  foremost  let  me  thank  my  parents,  Mr. D.  Radhakrishinan,
Mrs.  Jayamma  Radhakrishnan  and  to  my  husband  Mr.  Dileepkumar  for
extending  me  utmost  support  without  which  I  could  have  never  completed  my
master degree.
I  explain  my  extreme  sense  of  gratitude,  profound  thanks  to  my  guide
Mr. G Sekar, M. Pharm, Assistant Professor Department of Pharmacology for
his precious guidance, encouragement, inspiration, discussion and timely suggestion
which provided for the success of this work.
I am immensely thankful to my co-guide Mr A. Suresh, M. Pharm. (Ph.D)
Assistant Professor JKKMMRF College of Pharmacy for his extreme support to my
work.
I do feel highly elated in manifestation a sense of gratitude to my honourable
Principal  Dr.  N.  Senthilkumar,  M.Pharm,  Ph.D,  Mr.  K.G.  Parthiban,
M.Pharm.,  (Ph.D),  Vice Principal JKKMMRF College of Pharmacy  for their
support towards this work.
I show my regard to Mr. V.SURESH, M Pharm. (Ph.D), Asst. Professor
and Head of Department of Pharmacology JKKMMRF College of Pharmacy
for his support towards this work.
I submit my sincere thanks and respectful regard to our beloved Managing
Trustee,  Dr. JKK MUNIRAJAH M.Tech (Bolton), D.Lit.,  for all the facilities
that  were  provided  to  me at  the  institution  enabling  me  to  do  the  work  of  his
magnitude.
My sincere thanks to  Dr. Jomy Augustine.  M.Sc., M.Ed., PhD,  Professor
and Head of the Department of Botany St. Thomas College, Pala, Kottayam, for his
valuable guidance, authentication of my plant.
This  project  would  not  be  a  resplendent  one  without  timely  help  and
continuous support of my friend Surya and Bhanumathi, Assistant Librariyan, and
take opportunity to acknowledge them with thanks.
MONISHA. R.
Reg. No. 26116596
DEDICATED 
TO 
MY FATHER
CONTENTS
CHAPTER
NO. TITLE PAGE NO.
1 Introduction 1
2 Literature Review 39
3 Research Envisaged 40
4 Plan of Work 41
5 Collection and Identification 42
6 Botanical Information 43
7 Materials and Methods 47
8 Results and Discussions 73
9 Summary and Conclusion 97
10 Bibliography 98
Annexure
Introduction
Literature Review
Research Envisaged
Plan of Work
Collection and
Identification
Botanical Information
Materials and Methods
Results and Discussions
Summary and
Conclusion
Bibliography
ANNEXURE 1
ABBREVIATIONS
SGOT Serum glutamic pyruvic transaminase
SGPT Serum glutamic oxaloacetic transaminase
ALP Alkaline phosphatase
ROS Reactive oxygen species
NASH Non Alcoholic Steato Hepatitis
NAPQI N-acetyl-p-benzoquinone imine
NSAIDs Nonsteroidal anti-inflammatory drugs
LFTs liver function tests
GSH glutathione peroxidase
CAT Catalase
GSH glutathione peroxidase
SOD superoxide dismutase
HDL High Density Lipoprotein
LDL Low Density Lipoprotein
VLDL Very Low Density Lipoprotein
TP Total protein
ALT Alanine aminotransferase
AST aspartate amino transferase
LPOx Lipid peroxidase
IFCC International  federation  of  clinical  chemistry  and  laboratory
medicine
TG Triglycerides
AST Aspartate amino transferase
LPOx Lipid peroxidase
LD50 Lethal Dose
OECD Organization for economic co-operation and development
PO Per oral
Mg/dl Milligram per deciliter
Mg Milligram
NADH Nicotinamide adenine dinucleotide
BC Before Christ
CMC Carboxy methyl cellulose
GIT Gastro intestinal tract
U/L Unit per litre
ROI Reactive oxygen intermediate
RBC Red blood cells
GPx Glutathione peroxidase
HbAlc Glycosylated heamoglobin
ANNEXURE 2
Chapter 1 Introduction
INTRODUCTION
MEDICINAL PLANTS
Healing  with  medicinal  plants  is  as  old  as  mankind  itself.  The  connection
between man and his search for drugs in nature dates from the far past. Awareness of
medicinal plants usage is a result of the many years of struggles against illnesses due
to which man learned to pursue drugs in barks, seeds, fruit bodies, and other parts of
the plants. (Biljana Bauer Petrovska, 2012) India has a rich culture of medicinal herbs
and spices, which includes about more than 2000 species and has a vast geographical
area with high potential abilities for Ayurvedic, Unani, Siddha traditional medicines
but  only very  few have  been  studied  chemically  and  pharmacologically  for  their
potential medicinal value. 
Herbal medicine is  a major component in all indigenous people’s traditional
medicine.  In  India the use of the medicinal herbs is as old as 1500BC. Medicinal
herbs  have  been  in  use  for  thousands  of  years,  in  one  form or  other,  under  the
indigenous system of medicine like Ayurveda, Unani and Sidha. India has 13,000-
20,000 specious flowering plants, 2800 algae, 23,000 fungi, 1,600 types of latches,
1,800 varieties of bryophytes and an estimated 30 million types of microorganisms.
There  are  few  medicinal  herbs  of  commercial  importance,  in  context  with  the
abundant flora in India. India is perhaps the large producer of medicinal herbs and is
rightly called as “Botanical garden of the world”. Herbal medicines are prepared from
a  variety  of  plant  material  such  as  leaves,  stems,  roots,  barks,  etc.  They usually
contain many biologically active ingredients and are considered to be medicinal if
they possess  pharmacological  activities  of  possible  therapeutic  use.  Today,  herbal
drugs are coming back into prominence and many drugs commonly used today are of
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herbal  origin.  Indeed,  about  25 percent of  the prescription drugs  dispensed in  the
United States of America contain at least one active ingredient derived from plant
materials. Side effects of the conventional medicines such as antibiotics, antimicrobial
agents are the major problem. Over the years, some of the infectious organisms have
developed resistance to synthetic drugs hence more and more complications. Demand
for medicinal plant is increasing in both developing and developed countries due to
growing  recognition  of  natural  product  having  no  side-effects,  easily  available  at
affordable prices and sometime the only source of health care available to the poor
people. 
According to the World Health Organization (WHO) more than 1 billion people
rely to some extent on medicinal plants. The WHO has listed 22,000 plants around the
world having medicinal values. The extensive advances and development of science
of phyto-pharmaceuticals and hopes for remedies in chronic disease generated new
enthusiasm  in  the  research  workers  to  develop  herbal  medicines.  The  major
achievement  in  the  field  was  the  discovery  of  vincristine  and  vinblastine  in  the
madagascars periwinkle and it  make marked difference in the treatment of cancer.
Morphine, digitoxin, ergotamine and quinine are the some of the other excellent drugs
that obtained from different plant species (M. Hamayan et al.2006).
LIVER
The liver is the key organ regulating homeostasis in the body. It is involved
with almost all  the biochemical  pathways related to growth,  fight  against  disease,
nutrient supply, energy provision and reproduction. The liver is expected not only to
perform physiological  functions but also to protect  against  the hazards of harmful
drugs and chemicals.  Inspite of  tremendous scientific  advancement  in  the field  of
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hepatology in recent years, liver problems are on the rise. Jaundice and hepatitis are
two  major  hepatic  disorders  that  account  for  a  high  death  rate.  Presently,  a  few
hepatoprotective  drugs  and  that  too  from  natural  sources,  are  available  for  the
treatment of liver disorders. Hence, people are looking at the traditional systems of
medicine for remedies to hepatic disorders.(Feroz Z et al, 2013).
According to W.H.O about 25,000 people die in every year due to hepatic
diseases. The common ailments of liver are cirrhosis, cholestasis, hepatitis, hepatic
encephalopathy, portal hypertension, fulminate hepatic failure and certain tumors like
hepatoma in liver. It is estimated that 2 billion people around the world are infected
with hepatitis B virus and about 370 millions of these have the chronic form of the
disease.
Medicinal herbs are significant source of pharmaceutical drug and the latest
trends have shown increasing demand of phytodrugs and some medicinal herbs have
been proven hepatoprotective potential. Silymarin, a flavonol lignin mixture extracted
from silybum marianum (milk thistle) is a popular remedy for hepatic diseases. The
present  study  is  an  attempt  to  test  the  hepatoprotective  activity  of  Girardenia
zeylanica Dcne extract.
ANATOMY OF LIVER
Liver is the largest organ in the human body with a median weight of (1600-
1800 gms) in men and (1300-1400 gms) in women. The liver is a reddish brown organ
and having 4 lobes of unequal shape and size.   Lobes lies on the right side of the
abdominal cavity beneath the diaphragm. The liver has a right and a left lobe and
inside the two lobes there is a network of tubes, is called as biliary tree. Biliary tree
carries bile from liver to intestine which helps the digestion. The liver lies to the right
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side of the stomach and it is connected to two large blood vessels (hepatic artery and
portal  vein).  The hepatic  artery carries  blood from the aorta  in  heart,  whereas  the
portal  vein  carries  blood  from  the  gastrointestinal  tract and  also  from
the pancreas and spleen. These blood vessels are subdivide into capillaries and which
then lead to a lobule. Each lobule is made up of millions of liver cells which are the
basic  metabolic  cells  and  that  are  the  basic  functional  units  of  the  liver.  (Lena
Sibuleski, 2013)
Fig. 1
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Bile Ducts
The tubes that carry bile through the liver and gallbladder are known as bile
ducts and form a branched structure known as the biliary tree. Bile produced by liver
cells  drains  into  microscopic  canals  known  as  bile  canaliculi.  The  countless  bile
canaliculi join together into many larger bile ducts found throughout the liver.
These bile ducts next join to form the larger left and right hepatic ducts, which
carry bile from the left and right lobes of the liver. Those two hepatic ducts join to
form the common hepatic duct that drains all bile away from the liver. The common
hepatic  duct  finally  joins  with  the  cystic  duct  from  the  gallbladder  to  form  the
common bile duct, carrying bile to the duodenum of the small intestine. Most of the
bile produced by the liver is pushed back up the cystic duct by peristalsis to arrive in
the gallbladder for storage, until it is needed for digestion.
Blood Vessels
The blood supply of the liver is unique among all organs of the body due to
the  hepatic  portal  vein  system.  Blood traveling to  the  spleen,  stomach,  pancreas,
gallbladder, and  intestine passes through capillaries in these organs and is collected
into the  hepatic portal vein. The hepatic portal vein then delivers this blood to the
tissues of the liver where the contents of the blood are divided up into smaller vessels
and processed before being passed on to the rest of the body. Blood leaving the tissues
of the liver collects into the hepatic veins that lead to the vena cava and return to the
heart.  The  liver  also  has  its  own  system  of  arteries  and  arterioles  that  provide
oxygenated blood to its tissues just like any other organ.
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Lobules
The internal structure of the liver is made of around 100,000 small hexagonal
functional units known as lobules. Each lobule consists of a central vein surrounded
by 6 hepatic portal veins and 6 hepatic arteries. These blood vessels are connected by
many capillary-like tubes called  sinusoids, which extend from the portal veins and
arteries to meet the central vein like spokes on a wheel.
Each sinusoid passes through liver tissue containing 2 main cell types: Kupffer
cells and hepatocytes.
• Kupffer cells are a type of macrophage that capture and break down old, worn out
red blood cells passing through the sinusoids.
• Hepatocytes are cuboidal epithelial cells that line the sinusoids and make up the
majority of cells in the liver. Hepatocytes perform most of the liver’s functions –
metabolism, storage, digestion, and bile production. Tiny bile collection vessels
known as bile canaliculi  run parallel  to  the sinusoids on the other side of the
hepatocytes and drain into the bile ducts of the liver.
Histology of liver
The basic functional unit of liver is the liver lobule, a cylindrical structure,
several  millimeters  in  length  0.8  mm.  and  2  mm  in  diameter.  The  human  liver
contains 50,000 to 1, 00,000 lobules and which is constructed around a central vein
which  empties  into  a  hepatic  venule  than  the  hepatic  vein  finally  into  inferior
venacava.  The  hepatic  lobule  is  roughly  a  hexagonal  arrangement  of  plates  of
hepatocytes radiating outward from a central vein in the center in liver.
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The hepatic  acinus  consists  of  an  irregular  shaped  and  roughly ellipsoidal
mass  of  hepatocytes aligned around the hepatic arterioles  and portal  venules.  The
acinus is roughly divided into different zones that correspond to distance from the
arterial  blood  supply.  If  hepatocytes  are  closest  to  the  arterioles  are  the  best
oxygenated, while those farthest from the arterioles have  poorest oxygen supply.
Hepatocytes  are  the  main  important  functional  cells  of  the  liver  and  are
polygonal  in  shape.  Liver  cells  sides  can  be  in  contact  either  with  sinusoids  or
neighbouring  hepatocytes  the  mid  perform a  number  of  metabolic  endocrine  and
secretary functions. Roughly 80 percent of the mass of the liver is  contributed by
hepatocytes and are exceptionally active in synthesis of protein and lipids for export
and also synthesize and secrete very low density lipoproteins.
Glycogen  is  a  polymer  or  glucose  and  the  density  or  its  aggregates  in
hepatocytes varies dramatically depend on whether the liver is examined shortly after
the  meal  which  shows  abundant  glycogen  or  following  a  prolonged  fast  shows
minimal quantities of glycogen.
Sinusoids are the small canals formed by the plates of hepatocytes. Sinusoids
are approximately 8-10 ¹m in diameter. They are orientated in a radial direction in the
lobule. Sinusoids are low-pressure vascular channels that receive blood from terminal
branches of the hepatic artery and portal vein at the periphery of lobules and deliver it
into central veins. Sinusoids are lined with endothelial cells and flanked by plates of
hepatocytes. The space between sinusoidal endothelium and hepatocytes is called the
space  of  Disse.  Sinusoidal  endothelial  cells  are  highly  fenestrated,  which  allows
virtually unimpeded flow of plasma from sinusoidal blood into the space of Disse.
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Fig. 2 Histology of liver
FUNCTIONS OF LIVER
    1.  Carbohydrate metabolism
• Glugconeogenesis
• Glycogen synthesis & metabolism
The liver is especially important in maintaining a normal blood glucose level
in  body  and  can  break  down  glycogen  to  glucose  and  release  glucose  into  the
bloodstream when blood  have low glucose level. The liver also can convert amino
acids  into  lactic  acid  and  galactose  into  glucose.  The  liver  converts  glucose  to
glycogen and triglycerides for storage when blood glucose is high, as occurs just after
having a meal.
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2. Lipid metabolism
• Fatty acid synthesis
• Cholesterol synthesis &excretion
• Lipoprotein synthesis.
• Ketogensis converting the fatty acid ketone bodies.
Hepatocytes store some triglycerides, break down fatty acids to generate ATP,
synthesize lipoproteins, transport fatty acids, triglycerides and cholesterol to and from
the body cells, synthesize and use cholesterol to make bile salts.
3. Protein metabolism
• Synthesis of plasma proteins.
• Urea synthesis.
Hepatocytes de-aminate (remove the amino group, NH2) amino acids so that
amino acid can be used for the production ATP or converted to carbohydrate or fats.
The resulting toxic ammonia is   which is then converted into the much less toxic urea
and excreted in urine. Hepatocytes can also synthesize most plasma proteins, such as
alpha and beta globulins, albumin, prothrombin and fibrinogen.
4. Processing of drugs and hormones
• Metabolism, conjugation & excretion of steroidal & poly peptide hormones
The  liver  can  detoxify  substances  such  as  alcohol  or  excrete  drugs  like
penicillin, erythromycin, and sulfonamides into the bile. It can also chemically alter or
excrete thyroid hormones and steroid hormones such as estrogen and aldosterone.
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5. Excretion of Bilirubin:
Bilirubin, derived from the blood cells is absorbed by the liver from the blood
stream and secreted into bile. Most of the bilirubin in bile is metabolized in the small
intestine by bacteria and eliminate in to feces.
6. Phagocytosis:
The stellate reticulo-endothelial (Kupffer's) cells of the liver phagocytose aged
white blood cells, red blood cells and some bacteria. 
7. Storage
Liver is a good part in storage of glycogen,vitaminA,vitamin B12 and iron
PATHOPHYSIOLOGY OF LIVER
Liver diseases are considered as fatal & life threatening and it creates a serious
challenge to public health. Liver diseases are due to infection and / or exposure of
liver to various toxic substances such as different drugs or alcohol. Some times over
dosage of some drugs can also lead to liver damage. Now-a-day’s due to inadequacy
of  liver  protective  agents,  researchers  and  traditional  medicine  practioners  are
concentrate  in  herbal  based  remedies  for  the  various  liver  disorders.  Modern
medicines have little to offer for alleviation of hepatic disorders so there was no safe
hepatoprotective drug available for the treatment of liver disorders. Therefore, many
folk remedies from plantsource are used for the protection of hepatic disease starting
from ancient  period.  Liver  diseases  remain as  one of  the  serious  health  problems
however  we  do  not  have  satisfactory  liver  protective  drugs  in  allopathicmedical
practice.  So herbal drugs play a role in the management of various liver disorders
most of which speed up the natural healing processes. Numerous medicinal plants and
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their formulations are used for liver disorders in ethnomedical practices as well as
traditional system of medicine in India. 
Liver disease which cause an acute or chronic damage to the hepatic cells,
usually caused by infection (viral), exposure to some drugs or toxic compounds, an
autoimmune process, injury or by a genetic defect such as haemochromatosis. The
disease can be categorized by the effect it  has on the hepatic cells. Hepatitis is an
inflammation of the liver mostly by virus, cirrhosis involves irreversible scarring and
progressive  hepatic  cell  death,  stones  can  be  developed  and  which  form  cancer,
blockages and fatty liver, some of the cases can be life threatening. Genetic defect
may cause liver disease by depositing substances in the hepatic cell or preventing vital
functions of liver.
JAUNDICE
This is the yellow pigmentation of the skin, mucous membrane and deeper
tissue due to increased bilirubin level in blood. The normal serum bilirubin level is 0.5
to 1.5mg%. When this exceeds 2 mg%, jaundice occurs. (Maimburg et al., 2010).
Types and Causes of Jaundice 
Jaundice is classified into 3 types. Mainly Haemolytic jaundice,Hepatocellular
jaundice and obstructive jaundice.
a) Haemolytic jaundice
Haemolytic  jaundice  is  also  called  prehepatic  jaundice.   During  this,  the
secretary function of liver is normal.  But there is excessive destruction of RBCs and
thus the bilirubin level of blood is increased.  The liver cells excrete much bilirubin
rapidly.  So it accumulates in the blood resulting in jaundice.
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b) Hepatocellular Jaundice 
The Jaundice due to the damage of liver cell is called hepatocellular Jaundice.
Here bilirubin is conjugated.  But the conjugated bilirubin cannot be excreted. So it
returns to the blood. The damage of liver cells occurs because of toxic substance or by
infection.
c) Obstructive Jaundice
This is other wise called extra hepatic cholestatic jaundice.  It  is due to the
obstruction of bile flow at any level of biliary system. The bile cannot be poured into
small intestine and bile salts and bile pigments enter into circulation. 
HEPATITIS:
o There are two major forms of hepatitis.
o In acute hepatitis the liver is damaged quickly and in chronic hepatitis the liver
is damaged slowly only, over a long time.
o Hepatitis can be caused by several viruses that damage the liver, termed as
hepatitis viruses.  These viruses have been named according to their discovery
as hepatitis A, B, C, D, and E.
Hepatitis A
This infection is mainly caused by consuming contaminated food or water and
common victims are children. Most infected patient  do not even know about they
have been exposed to that particular virus.
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Hepatitis B 
It is fairly common disease and the virus can be spread one person to other by
exposure to blood, through sexual relations, and from mother to baby. Hepatitis B still
the most common cause of acute viral hepatitis. Vaccine is used prophylaxis purpose
only to prevent infection.
Hepatitis C
It is less common than hepatitis B as a cause of acute hepatitis, but in some
cases the majority of the people who contract it become chronically infected, hepatitis
c can able to spread through contact with infected blood, Hepatitis C infection can be
very serious. Most people infected experience no symptoms but the virus may remain
in the liver for years and it is not discovered until much damage is done. Up to fifty
percent of those infected with Hepatitis C are able to fight off the virus within six
months. However, many patients become develop a chronic infection. (David Baxter,
2013)
• Hepatitis D and E are rare.
LIVER CIRRHOSIS
Anything that causes severe ongoing damage to the hepatic cells can lead to
liver cirrhosis. It is marked by scar formation or cell death occur in hepatic cell and
which lead to a progressive disease that  creates irreversible damage of liver.  It  is
treated by trying to limit further damage to hepatic cells. The main causes of liver
cirrhosis include chronic excessive intake of alcohol, auto immune hepatitis caused by
auto immune reaction, primary biliary cirrhosis persistence hepatitis C or B virus and
by  inherited  metabolic  diseases  (Wilsons  disease).  Metabolic  and  clinical
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abnormalities  can  be  occur  later  stage  only.   The  main  causes  of  death  in  liver
cirrhosis include uncontrolled bleeding spaticaemia and long prothrombin time and
elevated level of bilirubin. Liver cirrhosis has no signs or symptoms in its preliminary
stages, but as it progresses, it can be cause fluid build-up in the abdomen cavity called
as cites, muscle wasting, bleeding from the intestines easy bruising, enlargement of
the breasts in men called as gynecomastia, and a number of other problems may be
occur. Liver function is monitored with such tests as albumin, bilirubin, prothrombin
time and a liver panel.
GALLSTONES
In gallbladder cholesterol and bile pigments (bilirubin) in the bile may form
stone. It  will cause symptoms and problems which depending upon their  size and
location of the stone. If stone present in gallbladder for a long time, they may damage
or block the duct that origins bile from the gallbladder and which causing sharp pain
to develop suddenly in the upper right pan of the abdomen cavity, and in some cases,
it may lead to the gallbladder fever.
OBSTRUCTION
Gallstones,  trauma,  tumors,  and  inflammation  can  cause  blockage  or
obstructions in the ducts draining the liver .When an obstruction occurs, bile and its
associated wastes accumulate in the liver cells and the patient's skin and eyes often
turn to yellow (Jaundice) bilirubin in the urine turns to dark brown in color.
FATTY LIVER
Fatty  liver  which  leads  to  enlargement  of  liver,  tenderness,  and  abnormal
functions of liver may be occurs. There are two major cause of fatty liver disease that
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including excessive alcohol  consumption and non alcoholicsteato hepatitis.  In  first
condition of fatty liver in which common cause is intake of excessive alcohol and it is
a reversible condition usually resolving with abstention from alcohol. Second cause of
fatty liver is non alcoholicsteatohepatitis  the most common chronic hepatitis is not
caused by some viruses.  It  is  commonly seen  in  overweight  and diabetic  patient.
Excess fat in liver can be lead to inflammation, progressing to scarring (or cirrhosis)
in  30  percent  of  patients.  Treatment  of  fatty  liver  includes  weight  loss,regular
exercise, regulating blood pressure and diabetes, cholesterol levels, limiting or stoping
of alcohol consumption and not smoking.
LIVER CANCER
Liver cancer may be caused by hepatitis and cirrhosis in some limited cases
only, but cancer from any other parts of the body that spreads in to the liver is more
common cause. It is better patient who have chronic hepatitis disease or liver cirrhosis
may be checked on a regular basis for cancer, often with an Alpha-Fetoproteins (AFP)
test  or  an  ultrasound.  Infiltrative  conditions  which  can be affect  the  liver  include
lymphomas and amyloidosis.
INHERITED ABNORMALITIES IN LIVER METABOLISM
There are four different conditions in which jaundice is caused by inherited
abnormality of Bilirubin metabolism are gilberts, crigler – najjar, Dubin – Johnson&
rotor syndromes.  Gilbert’s syndrome affects 2-3% of the population but the others are
rare and the patient  with Gilberts syndrome decreased conjugation of blood.  The
jaundice of Gilbert’s syndrome is typically mild & present only intermittently. It  is
often noticed after an infection. The liver will be histologically normal.
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• Wilsons disease characterized by decreased biliary excretion of copper in liver. It
is an inherited abnormality of copper metabolism in liver.  Copper is deposite or
accumulated in the hepatic cells and patients having Wilsons diseases may present
in child hood with hepatitis accompanied by renal tubular defect and haemolysis
or in children with cirrhosis may be happen.
• Hereditary  Hemochromatosis  –  The  common  adult  genetic  liver  disease  in
which a specific genetic defect lead to iron accumulation in the liver cells, leading
to hepatic cells cancer and liver cirrhosis in some patients. Iron accumulation may
go beyond the liver  affecting the joints,  heart  and pancreas.  Specific  effective
treatments  are  available  for  Hemochromatosis.  Liver  transplantation  may  be
required in some of these patients.
• Alpha-1 antitrypsin deficiency (Alpha-1) – This inherited disease affect the liver
and the lungs in patient which is caused by an inability to produce enough amount
of a particular protein, called Alpha-1 antitrypsin, which is used to prevent the
breakdown  of   some  enzymes  in  various  organs.  Management  of  Alpha-1
antitrypsin deficiency includes maintaining normal nutrition, patient education.
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HEPATOTOXICITY – DIFFERENT MECHANISMS
Damage to the  hepatic cells is not due to the drug itself but due to the over
dosage which leads production of a toxic metabolite N-acetyl-p benzoquinonimine
(NABQI or NAPQI) which is produced by cytochrome P 450 enzymes in liver cell.
In  overdoses of  some  drugs,  large  amount  of  NAPQI  is  generated  which
overwhelm the detoxification process and leads to  injury to liver cells. Nitric acid
have  some role in inducing liver toxicity.  Hepatotoxicity caused by NSAIDs were
documented  to  be  both  idiosyncratic reaction and  dose  dependant reaction.  Eg:
Intrinsic hepatotoxicity associated with aspirin and phenylbutazone  and  Ibuprofen,
sulindac,  phenylbutazone,  piroxicam,  diclofenac  and  indomethacin  has  been
associated with idiosyncratic reaction. Long term use of steroid in children which lead
to enlarged liver cells. (Kuester et al., 2002).
Carbon tetrachloride
Liver injury due to carbon tetrachloride in rats was reported in 1936 and has
been most  commonly and  successfully  used  by  many  investigators.  Carbon
tetrachloride (CCl4) is  metabolized  by  cytochrome  P-450  in  mitochondria  and
endoplasmic reticulum with CC13O- formation, a reactive oxidative free radical, which
initiates lipid peroxidation process.
                                          CCl4-----------------► CCl3O-  +  O-
The secondary mechanisms could involve the generation of  toxic products
arising  directly  from  metabolism  of  CCl4 or  from  peroxidative  degeneration  of
membrane lipids. The possible involvement of radical such as trichloromethyl (·CCl3),
trichloromethylperoxy  (·OOCCl3),  and  chlorine  (·Cl)  free  radicals,  as  well  as
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phosgene  and  aldehydic  products  of  lipid  peroxidation,  as  toxic  intermediates.
(Sharma Nidhi et al., 2012).
Single dose administration of CC14 to a rat produces  a  centrilobular necrosis
and  fatty  changes,  within  24 hours.  After  administration  the  poison  reaches  its
maximum concentration in the liver within three hours. Thereafter, the level  of CCl4
falls and by 24 hrs there is nor remaining in the liver. The development of necrosis is
associated with small leakage of hepatic enzymes into serum.
Dose of carbon tetrachloride: 0.1 to 3 ml/kg I.P.
Galactosamine
It produces  diffuse  type  of  liver  damage simulating the viral  hepatitis.  It
presumably  disrupts  the  synthesis  of  essential  uridylate  nucleotides  that  cause
organelle  damage and  cell  death may  happen  in  last  stage.  Reduction  of  those
nucleotides would impede the normal synthesis of RNA and decline protein synthesis.
This mechanism of toxicity brings about an increase in cell membrane permeability
in  hepatic  cells  leading  to  leakage  of enzyme  and  eventually  cellular death.
Galactosamine may cause cholestasis and from its damaging effects on bile ducts or
ductless or canalicular membrane.  Galactosamine decrease the flow of bile and its
content (bile salts, deoxycholic acid and cholic acid). 
Dose-  D-Galactosamine: 400 mg/kg, I.P.
Thioacetamide
Thioacetamide mechanism  interferes  with  the  transport of  RNA from  the
nucleus  to  cytoplasm  which  may  cause  membrane  damage.  A  thioacetamide
metabolite (perhaps s-oxide) is responsible for hepatic cell damage. It will reduce rate
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of oxygen consumption as well as the number of viable hepatocytes. It also decreases
the amount of bile and its content ( bile salts, cholic acid and deoxycholic acid).
Dose -  Thioacetamide: 100 mg/kg, S.C.
Alcohol
 During  the  oxidation process,  ethanol  enhances the generation of  oxyfree
radicals. The peroxidation of membrane lipids in liver cell results in loss of membrane
integrity and structure. This results in elevated levels of membrane bound enzyme (i-
glutamyltranspeptidase)  in  serum.  Alcohol  inhibits antioxidant  enzyme  such  as
glutathione peroxidase, decrease the activity of catalase, superoxide dismutase, along
with increase in levels of glutathione in liver. The decrease in activity of antioxidant
enzymes superoxide dismutase, glutathione peroxidise damages the liver cells.  By
oxidation of ethanol free radicals  are produced. Alcohol pre-treatment stimulates the
toxicity  of  carbon  tetrachloride  due  to  increased  production  of  toxic  reactive
metabolites  such  as  trichloro-methyl  radical  by  the  microsomal  mixed  function
oxidative system. This activated free radical binds covalently to the macromolecules
and  induces this  lipid  peroxidative  degradation  of  biomembranes  is  the  principle
reason of hepatotoxity.
Paracetamol
Paracetamol, a commonly used analgesic and antipyretic  agent, over dosage
which  will  damage the  liver  is  not  due  to  the  drug  itself  but  a  toxic  metabolite,
example (N-acetyl-p-benzoquinone imine NAPQI, or NABQI) which is produced by
cytochrome P-450 enzymes in the liver.  In  normal dose,  the drug is  detoxified by
conjugating with glutathione in phase 2 reaction but in an overdose, a large amount of
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N-acetyl-p-benzoquinoneimine  is  generated  which  overwhelms  the  detoxification
process  and  leads  to  centrilobular  hepatocytes  necrosis  which  is  characterized  by
nuclear eosinophilic and pyknosis cytoplasm followed by hepatic lesion. The covalent
binding  of  paracetamol  toxic  metabolite,  N-  acetyl-P-benzoquinonimine  to
sulphydrylgroups of the protein, result in lipid peroxidative degradation of glutathione
(antioxidant enzyme) level that also leads to cell necrosis in the liver cells.
Nonsteroidal anti-inflammatory drugs (NSAIDs)
NSAIDs have emerged as a major group of drugs  that  exhibiting both dose-
dependent and idiosyncratic reactions which leads to chronic liver damage.  Example-
idiosyncratic  reaction  has  been  related  to ibuprofen,  sulindac,  phenylbutazone,
piroxicam, diclofenac and indomethacin and aspirin and phenylbutazone are related to
intrinsic hepatotoxicity. (Aashih Pandit et al., 2012). 
Glucocorticoids
Glucocorticoids  affect  on  the  carbohydrate  mechanism.  Glucocorticoids
promote glycogen storage in the liver. Long-term steroid use in children leads to the
enlarged liver which is a rare side effect. Steatosis may be happen in prolonged usage
both in adult and paediatric population.
Isoniazid
Isoniazide (INH) is one of the most commonly used  in combination therapy
for  tuberculosis.  It  is  associated with mild elevation of liver enzymes in up to 20
percentage of patients and severe hepatotoxicity in 1-20 percentage of patients.
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Natural products
 Example for natural products include many amanita mushroom and aflatoxins
LIVER FUNCTION TESTS
As the liver performs it’s different functions and it makes chemicals that pass
into the bloodstream and bile. There are large variety of liver disorders which can
alter the blood level of these chemicals. Some of these chemicals can be measured in
the blood called liver function tests (LFTs). 
SERUM BILIRUBIN
Bilirubin derived from haemoglobin degradation process from the red blood
cells (RBC).It is an endogenous anion. Measurement of bilirubin level in blood by
direct and indirect bilirubin method. It is based on the original Van der Bergh method.
Bilirubin values will alter when exposed to light. So serum and plasma samples must
be kept  in dark before measurements.  When the liver  function tests  are abnormal
(serum bilirubin levels more than17µmol/L)  it suggest that liver having some disease.
(Friedman SF et.al. 2003)
Types of bilirubin
i. Total bilirubin: Normal range is 0.2-0.9 mg/dl (2-15µmol/L). This is measured as
the amount, which will reacts in 30 minutes after addition of alcohol and it is higher
slightly (3-4 µmol/L) in males as compared to females. This helps to diagnose Gilbert
syndrome in males easily.
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ii. Direct Bilirubin:  Normal range 0.3mg/dl (5.1µmol/L). This is the water-soluble
fraction. Direct bilirubin is measured by the reaction with diazotized sulfanilic acid in
1 minute and it gives estimation of conjugated bilirubin. 
iii.  Indirect  bilirubin:  This  fraction  is  calculated  by the  difference  of  the  direct
bilirubin and total bilirubin and it is a measure of unconjugated fraction of bilirubin.
(Daniel SP, Marshall MK.1999)
Any  elevation  in  bilirubin  level  which  shows  the  depletion  of  hepatic
clearance.  Mild  elevation  is  due  to  inherited  hyperbilirubinemias,  physiological
jaundice and moderate elevation due to some drugs,  inherited hyperbilirubinemias,
and  viral  hepatitis.  In  diazo  method,  bilirubin  estimation  is  not  very  accurate
especially when used in detecting low levels of bilirubin. Direct bilirubin method over
estimates bilirubin esters at  low bilirubin levels and under  estimates them at  high
concentration.(Shivaraj Gawda et.al., 2009)
ENZYMES THAT DETECT HEPATOCELLULAR NECROSIS
Aminotransferases
The  aminotransferases  (formerly  transaminases)  are  specific  indicators  of
hepatocellular necrosis. These enzymes- aspartateamino transferase (AST, formerly
serum  glutamateoxaloacetic  transaminase-S  GOT)  and  alanine  aminotransferase
(ALT, formerly serum glutamic pyruvatetransaminase-SGPT) catalyze the transfer of
the aminoacids of aspartate and alanine respectively to the á ketogroup of ketoglutaric
acid. ALT is primarily localized to the liver but the AST is present in a wide variety of
tissues  like  the  heart,  kidney,  skeletal  muscle,  brain and  liver.  (B.R.  Thapa,  Anuj
Walia, 2007).
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Alanine transaminase (ALT)
It  is  an  enzyme that  helps  to  speed  up  chemical  reactions in  liver. Large
amounts of ALT occur in liver cells but the blood level of ALT usually rises when the
liver is injured or inflamed (such  as in hepatitis), and elevated level in ALT which
shows leakage from damaged tissue,  and the marked elevation may be caused by
hepatitis, autoimmune disease, toxic, neonatal hepatitis and ischemia. 
Aspartate aminotransferase (AST)
This is an enzyme usually found inside liver cells. However if heart or skeletal
muscle is damaged AST can also be released. If the patient blood test result showing
high levels of aspartate aminotransferase usually means the liver is damaged in some
way. For this reason ALT is usually considered to be more specifically related to liver
problems.
Alkaline phosphatase (ALP)
The blood level alkaline phosphatases is raised in some types of liver and bone
disease.  Alkaline phosphatases are zinc metalo-enzymes and in liver, it is found in
microvilli of bile canaliculi and also in the sinusoidal surface of hepatocyte.
Average  level  of  alkaline  phosphatase  may be  varying  with  age.  Example
lower level in middle age and relatively high in childhood and puberty and higher
again in old age.  Higher  values  alkaline phosphatase in males  when compared to
females. The levels of the enzyme correlate inversely with the height of the person,
and directly with person’s weight (Kuldp Singh, 2013).  The mechanism by which
alkaline  phosphatase  reaches  the  circulation  is  uncertain;  leakage  from  the  bile
canaliculi  into hepatic  sinusoids may result  from leaky tight  junctions,  (M. Adak,
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Shivapuri, 2010), and the other hypothesis in acute viral hepatitis alkaline phosphatise
level is usually either normal or moderately increased because of damaged liver fails
to  excrete  alkaline  phosphatase  made  in  bone,  intestine  and  liver.  Tumours  may
secrete alkaline phosphatase into plasma and there are tumour specific isoenzymes
such as Regan, Nagao and Kasahara isoenzymes. In patients with cirrhosis elevated
serum levels of intestinal alkaline phosphatase have been found, particularly those
with blood group type O, and may be associated specifically with intra hepatic disease
(M. Adak, Shivapuri 2010).
Elevated  levels  of  alkaline  phosphatase  also  may  present  in  patient  with
hepatic and bony metastasis. However some hepatic diseases may also cause a rise in
alkaline  phosphatase  level.  Example  are  infiltrative  liver  diseases,  abscesses,
granulomatous liver disease and amyloidosis. In cirrhosis and hepatitis of congestive
cardiac failure mildly elevated levels of alkaline phosphatase may seen. In  patient
with  hypothyroidism,  pernicious  anemia,  zinc  deficiency  and  congenital
hypophosphatasia levels of alkaline phosphatase will be low.
Albumin
This is the major protein in blood which can bind most of the drugs which will
resulting increasing the duration of action of that specific drug. Albumin synthesis in
liver and it release in to blood stream. Some of the liver disorder may affect the ability
to make albumin (and other proteins). Albumin synthesis stimulated by corticosteroids
and thyroid hormone. In  some liver disorders like cirrhosis, ascites   a low level of
blood albumin occurs.
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Total protein
This  measures  albumin  and  all  other  proteins  in  blood  including  alpha  1
antitrypsin, alpha feto protein.
Bilirubin
This chemical gives bile its yellow/green colour. A high level of bilirubin in
blood  will  make  jaundiced  ('yellow').  Bilirubin  is  made  from  haemoglobin.
Haemoglobin is a chemical in red blood cells that is released when the red blood cells
break down. Liver cells take in bilirubin and attach sugar molecules to it. This is then
called 'conjugated' bilirub in which is passed into the bile ducts.
A raised blood level of 'conjugated' bilirubin occurs in various liver and bile
duct conditions. It is particularly high if the flow of bile is blocked. For example, by a
gallstone stuck in the common bile duct, or by a tumour in the pancreas. It can also be
raised with hepatitis, liver injury, or long-term alcohol abuse.
A raised  level  of  'unconjugated'  bilirubin  occurs  when  there  is  excessive
breakdown of red blood cells. For example, in haemolytic anaemia.
Role of Liver function tests
• To diagnose liver disorders.
• To monitor the activity and severity of liver disorders.
• As a routine precaution after starting certain medicines to check that they are
not causing liver damage as a side-effect.
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FREE RADICALS
Types of free radicals
Free  radicals  can  be  defined  as  molecules  containing  a  single  unpaired
electron in atomic or molecular orbits. These molecules are highly reactive ion and
have an important role in the pathogenesis of tissue damage in various disorders such
as hepatic dysfunction, mastitis, kidney damage, inflammation, immune injury and
carcinogenesis (AbdEllah, 2010). The most important free radicals include superoxide
anion (O2.−), hydroxyl radical (.OH), and hypochlorous acid (HOCL) (Stohs, 1995).
HOCL is produced by the reaction of hydrogenperoxide (H2O2) with chloride ions and
plays an important role in the leukocyte respiratoryburst, which is involved in the host
defense system (Lunec,  1990).  Nitric  oxide (NO.)  acts  as  a  free radical  and  as  a
biological mediator in biochemical reactions. Physiologically it is synthesized from L-
arginine by NO synthase employing cofactor NADPH. In the host, NO arises in some
pathological  situations,  such  as  sepsis,  stroke,  myocardial  depression,  and
inflammatory responses. (Bredt & Snyder,1994)
Superoxide anion induces important reducing reactions in biological materials
via Fenton like reactions, which are catalyzed by redox cycling metal ions, including
iron, copper, chromium and vanadium (Stohs & Bagchi, 1995). These metal ions have
the ability to accept and donate single electrons, making them important catalysts of
free  radical  reactions,  the  most  widely  distributed  and  most  commonly  studied
transition metal ions are the cations iron and copper, (Stohs,1995)．Superoxide anion
reduces Fe3+ in metalloproteins such as ferritin. The reduction of protein bound iron
is an important reaction in biological material, because if there is sufficient H
２
O
２
available, a reaction between the resultant Fe2+ and H
２
O
２
occurs and gives rise to
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the highly reactive .OH (Lunec, 1990). H
２
O
２ 
traverses biological membranes and
intracellularly targets  phospholipids,  carbohydrates,  metalloproteins  and DNA, and
causes  damage  via  Fenton’s  reaction.  The  main  characteristics  are  short  living,
unstable, react with other molecules to achieve stability.
Sources of free radicals
Free radicals may be released due to the by-product of cellular respiration.
synthesized  by  enzyme  system  (phagocytic  cell,  neutrophils  and  macrophages),
exposure  to  ionizing  radiation,  smoking,  herbicides,  pesticides,  fried  foods  or  the
production by chain reaction and normal cellular respiration, 
Free  radicals  may  be  produced  in  the  liver  as  a  subsequence  to  hepatic
detoxification of drugs, chemicals and toxic materials, (Feheret al.1992) (Ogino &
Okada,  1995).  The formation  of  oxygen  free radicals  may be  physiological  as  in
phagocytosis (superoxide and H
２
O
２
 are used by phagocytic cells to kill bacteria), a
side effect of metabolic pathways,  or may occur in pathological  conditions due to
toxic agents as in the case of ischemia, inflammation, disease, or due to decreased
antioxidant defences.
Mitochondria considered a major source for the production of O2.- and H ２ O
２
,  about  2-3%  of  consumed  oxygen  is  constantly  converted  into  reactive
oxygen/reactive  nitrogen  species  (ROS/RNS)  in  the  mitochondria,  hepatocytes
contain many mitochondria and therefore, generate excess ROS/RNS (Stohs,1995)．
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In  many liver  diseases,  including the wide range of  neonatal  hepatitis,  the
tissue inflammatory infiltrates are likely to be responsible for the formation of O2.-, H
２
O
２
, OH, HOCl and the highly cytotoxic monochloramine.
In turn, the superoxide anion attracts further neutrophils to the inflammatory
site  by  a  chemotactic  activity,  causing  an  increase  in  tissue  injury.  In  addition,
activated macrophages,  Kupffer cells and vascular endothelium can generate nitric
oxide,  which  may  react  with  superoxide  generating  peroxynitrite.  The  latter  is
responsible for the inhibition of mitochondrial respiration and DNA synthesis. 
Liver damage due to iron (hemochromatosis) and copper overload is believed,
at least partially, to derive from the catalytic activity of these metals in the Fenton
reaction  leading  to  the  generation  of  ROS  and  increased  lipid  peroxidation  with
consequent abnormal mitochondrial function.
Excessive  free  radical  production  has  been  involved  in  the  occurrence  in
several disease processes like drug toxicities, inflammation, aging etc.
Antioxidants
The cells contain a variety of antioxidant mechanisms that play a central role
in  the  protection  against  reactive  oxygen  species  (Halliwell  et  al.  1991).  The
antioxidant  system consists  of  antioxidant  enzymes  (superoxide  dismutase (SOD),
catalase (CAT) and glutathione peroxidase (GSH-Px)), glutathione, ancillary enzymes
(glutathionereductase  (GR),  glutathione  S-transferase,  and  glucose  6-phosphate
dehydrogenase  (G6PD)),metal-binding  proteins  (transferrin,  ceruloplasmin  and
albumin), vitamins (α-tocopherol, ascorbate and beta-carotene), flavonoids, and urate
(Halliwell, 1994).  Pathological free radical reactions do not necessarily cause cell and
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tissue damage, as  antioxidants of cells and tissues  are able to prevent free radical
injury. (Feher et al,1992)
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Hepatic oxidative stress and lipid peroxidation
The term “oxidative stress” has been coined to represent a shift towards the
pro-oxidants in the pro-oxidant/antioxidant balance that can occur as a result of an
increase in oxidative metabolism. Increased oxidative stress at the cellular level can
come  about  as  a  consequence  of  many  factors,  including  exposure  to  alcohol,
medications,  trauma,  cold,  infections,  poor  diet,  toxins,  radiation,  or  strenuous
physical  activity.  Protection  against  all  of  these  processes  is  dependent  upon  the
adequacy  of  various  antioxidant  substances  that  are  derived  either  directly  or
indirectly from the diet.
Consequently, an inadequate intake of antioxidant nutrients may compromise
antioxidant potential, thus compounding overall oxidative stress.
Oxidative stress results when reactive forms of oxygen are produced faster
than they can be safely neutralized by antioxidant mechanisms (Sies, 1991) and/or
from a  decrease  in  antioxidant  defense,  which  may lead  to  damage of  biological
macromolecules and disruption of normal metabolism and physiology. (Trevisan et al,
2001). This condition can contribute and/or lead to the onset of health disorders and
play a  damaging role in  a  number  of  liver  disorders,  for  example,  in  anoxic and
reoxygenation  injury  during  transplantation,  activated  phagocytes  and  xanthine
oxidase  formed  during  ischemia,  catalyze  the  formation  of  superoxide  during
reperfusion.
Lipid  peroxidation  is  implicated  in  the  pathogenesis  of  several  hepatic
disorders in human  and animals (AbdEllah et al., 2004). Hepatic failure in cattle was
associated with decreased antioxidant mechanisms inside the cells, which led to the
increase in the reactive oxygen species, especially H
２
O
２
. The decrease in hepatic
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GSH-Px activity in severe fatty degeneration, for example, results in the increase H
２
O
２
 (AbdEllah et al., 2004), which can initiate free radical formation through Fenton’s
reaction. In addition, the decrease in hepatic vitamin E level, which is an important
chain breaking antioxidant, results in lipid peroxidation and failure to regenerate the
ascorbic acid (Mudroň et al., 1997, 1999). Increased hepatic oxidative stress was also
reported  in  cows  suffering  from  glycogen  degeneration  (AbdEllah  et  al.,  2004),
sawdust liver and liver abscesses (Sayed et al., 2003). The authors contended that the
antioxidant defense was high in the case of sawdust liver, glycogen degeneration, and
liver abscess,  which indicated that the body can combat the increased free radical
stress.
Liver abscesses in fattening steers occur mainly due to intensive feeding of
highly  concentrated  rations.  Consumption  of  a  carbohydrate-rich  diet  stimulates
G6PD expression in endothelial and parenchymal cells (Spolarics, 1999). Since G6PD
supports  reactive  oxygen  metabolism,  the  response  may  represent  an  antioxidant
pathway in the hepatic  cell  populations that  targets sinusoid born reactive oxygen
species during infections (Spolarics, 1999; AbdEllah et al., 2002).
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ANTIOXIDANTS AND IT’S ROLE IN LIVER PROTECTION
The  ability  to  utilize  oxygen  has  provided  humans  with  the  benefit  of
metabolizing fats, proteins, and carbohydrates for energy; however, it does not come
without cost. Oxygen is a highly reactive atom that is capable of becoming part of
potentially damaging molecules commonly called “free radicals”.  Free radicals are
capable of attacking the healthy cells of the body, causing them to lose their structure
and function.  Cell damage caused by free radicals appears to be a major contributor
to aging and to degenerative diseases of aging such as cancer, cardiovascular disease,
cataracts, immune system decline, and brain dysfunction. Overall, free radicals have
been  implicated  in  the  pathogenesis  of  at  least  50  diseases  (Langseth,  L,  1993).
Fortunately,  free  radical  formation  is  controlled  naturally  by  various  beneficial
compounds  known  as  antioxidants.  It  is  when  the  availability  of  antioxidants  is
limited that this damage can become cumulative and debilitating.  Free radicals are
electrically  charged  molecules,  i.e.,  they have  an  unpaired  electron,  which  causes
them to seek out and capture electrons from other substances in order to neutralize
themselves.
Although  the  initial  attack  causes  the  free  radical  to  become  neutralized,
another free radical is formed in the process, causing a chain reaction to occur. And
until subsequent free radicals are deactivated, thousands of free radical reactions can
occur with in seconds of the initial reaction. Antioxidants are capable of stabilizing, or
deactivating, free radicals before they attack cells. Antioxidants are absolutely critical
for maintaining optimal cellular and systemic health and well-being.
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REACTIVE OXYGEN SPECIES
Reactive  oxygen  species  (ROS)  is  a  term  which  encompasses  all  highly
reactive, oxygen-containing molecules, including free radicals. Types of ROS include
the hydroxyl radical, the superoxide anion radical, hydrogen peroxide, singlet oxygen,
nitric oxide radical, hypochlorite radical, and various lipid peroxides. All are capable
of reacting with membrane lipids, nucleic acids, proteins and enzymes and other small
molecules, resulting in cellular damage.
ROS are generated by a number of pathways. Most of the oxidants produced
by cells occur as:
• A consequence  of  normal  aerobic  metabolism:  approximately  90%  of  the
oxygen  utilized  by  the  cell  is  consumed  by  the  mitochondrial  electron
transport system.
• Oxidative burst from phagocytes (white blood cells) as part of the mechanism
by  which  bacteria  and  viruses  are  killed,  and  by  which  foreign  proteins
(antigens) are denatured.
• Xenobiotic metabolism, i.e., detoxification of toxic substances. 
Consequently,  things  like  vigorous  exercise,  which  accelerates  cellular
metabolism;  chronic  inflammation,  infections,  and  other  illnesses;  exposure  to
allergens and the presence of “leaky gut” syndrome; and exposure to drugs or toxins
such as cigarette smoke, pollution, pesticides, and insecticides may all contribute to
an increase in the body’s oxidant load.
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ANTIOXIDANT PROTECTION
To protect  the  liver  cells  and  organ  systems  of  the  body against  reactive
oxygen species, humans have evolved a highly sophisticated and complex antioxidant
protection  system.  It  involves  a  variety  of  components,  both  endogenous  and
exogenous in origin, that function interactively and synergistically to neutralize free
radicals.
These components include:
• Nutrient-derived antioxidants like ascorbic acid (vitamin C), tocopherols and
tocotrienols  (vitamin  E),  carotenoids  and  other  low  molecular  weight
compounds such as glutathione and lipoic acid.
• Antioxidant enzymes, e.g., superoxide dismutase, glutathione peroxidase, and
glutathione reductase, which catalyze free radical quenching reactions.
• Metal  binding  proteins,  such  as  ferritin,  lactoferrin,  albumin,  and
ceruloplasmin that  sequester  free  iron and  copper  ions  that  are  capable  of
catalyzing oxidative reactions.
• Numerous other antioxidant phytonutrients present in a wide variety of plant
foods.
DIETARY ANTIOXIDANTS
Vitamin C, vitamin E, beta carotene and lycopene are among the most widely
studied  dietary  antioxidants.  Lycopene  is  carotenoid pigment  and  phytochemical
found in tomatoes and other red fruits and vegetables. Water-soluble antioxidant  eg-
vitamin  C  is  capable  of  neutralizing  ROS  in  the  aqueous  phase  before  lipid
peroxidation is  initiated.  Lipid-soluble antioxidant vitamin E, a  major,  is the most
effective  chain-breaking  antioxidant  within  the  cell  membrane  where  it  protects
membrane fatty acids from lipid peroxidation.
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ENDOGENOUS ANTIOXIDANTS
In  addition  to  dietary antioxidants,  the  body relies  on  several  endogenous
defense  mechanisms  to  help  protect  against  freeradical-induced  cell  damage.  The
antioxidant  enzymes  –  glutathione  peroxidase,  catalase  and  superoxide  dismutase
(SOD) – metabolize oxidative toxic intermediates and require micronutrient cofactors
such as selenium, iron, copper, zinc, and manganese for optimum catalytic activity. It
has  been suggested that  an inadequate  dietary intake  of  these trace  minerals  may
compromise the effectiveness of these antioxidant defense mechanisms (Duthie, G.G.,
and Brown, K.M., 1994) Research indicates that consumption and absorption of these
important  trace  minerals  may decrease  with aging.  Intensive  agricultural  methods
have also resulted in significant depletion of these valuable trace minerals in our soils
and the foods grown in them.  Glutathione, an important water-soluble antioxidant, is
synthesized  from  the  amino  acids  glycine,  glutamate  and  cysteine.  Glutathione
directly  quenches  ROS  such  as  lipid  peroxides,  and  also  plays  a  major  role  in
xenobiotic metabolism.
Free  radicals  are  highly  reactive  substances  produced  continuously  during
metabolic  processes.  They  participate  mainly  in  physiological  events  such  as  the
immune response, metabolism of unsaturated fatty acids and inflammatory reaction.
The balance between free radicals and antioxidants is disrupted in many diseases. This
disruption may be attributed to a number of factors such as the inability of the cells to
produce sufficient amounts of antioxidants, the nutritional deficiency of minerals or
vitamins, and the excess production of reactive oxygen species. (AbdEllah, 2010). 
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DRUG PROFILE
CARBON TETRACHLORIDE
Chemical Structure
  Molecular formula : CCl4  
  Molecular mass : 158.82 gm/mol
  IUPAC Name : Tetrachloromethane
  Other names : Benziform, Carbon Tet, Tetrazol
  Appearance : Colourless liquid
Odor : Ether like odor.
  Density : 1.5867 gm/cm3
 Melting point : -22.92º C
 Boiling point : 76.72º C
 Solubility : Soluble in alcohol, ether, CHCl3, Benzene.
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USES
It  was  widely  used  as  a  dry  refrigerant,  cleaning  solvent,  in  detection  of
Neutrinos. It is one of the most potent hepatotoxins and is widely used in scientific
research to evaluate hepatoprotective agents. 
SILYMARIN (reference drug)
A mixture of the isomers Silibinin, Silicrystin and Silidianin and the active
principle from the fruit of Silybum marianum (Carduus marianus) (Compositae).The
principle components  are the Silibinin,  silicrystin,  silidianin and flavonolignans of
which Silibinin is the major component.
Chemical Structure of Silymarin
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PICTURE OF SILYMARIN
Fig. 3
Chemical Name : 2,3-Dihydro-3-(4-hydroxy-3-methoxyphenyl) –
2(hydroxymethyl)-6-(3,5,7-trihydroxy-4- oxobenzopyran-
2-yl) benzodioxin.
Molecular Formula : C25H22O10
Molecular Weight : 482.44
Scientific name : Milk Thistle
Other Names : Carduimariae, Mary Thistle, Holy Thistle, Lady's Thistle, 
Marian Thistle, Mariendistel, Our Lady's Thistle, 
Silimarina, Carduusmarianum, Silybin, Silybummarianum,
St. Mary Thistle, Legalon
PROPERTIES
Hepato-protective: Protects liver cells from incoming toxins, thereby also allowing it
to more effectively process and release toxins that are already built up in  system.
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Hepato-tonic: Strengthen the liver to function more effectively.
Anti-depressant: By helping to move stagnant liver energy.
Demulcent: Soothes and moistens bladder and kidneys irritations, as well as mucous
membranes and inflammations of the skin and integumentary system.
Laxative: Mildly lubricates the bowels.
HEPATOPROTECTIVE ROLE OF SILYMARIN
Silymarin has shown differing degrees of effectiveness for protecting the liver
from  damage  caused  by  some drugs,  alcohol,  chemicals,  diseases  and  poisonous
plants. It  is used to treat  both acute conditions (such as poisoning) and long term
diseases (such as Hepatitis C). (Pradhan & Girish, 2006)
• Silymarin and other chemicals in milk thistle are believed to protect liver cells
in several different ways.
• Silymarin  has  antioxidant  properties/free  radical  scavenging  effect  and  has
been used for the treatment of liver disorders.
• Anti-inflammatory effects of Silymarin help in preventing hepatic cells from
swelling after being injured.  
• Silymarin seems to encourage the liver to grow new cells, while discouraging
the formation of inactive fibrous tissue.
• By changing the outside layer of liver cells, Silymarin actually may keep away
certain harmful chemicals from getting into liver cells. 
• Milk thistle may also cause the immune system to be more active
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LITERATURE REVIEW
1) P.S. Bedi et al., Reported that invitro antimicrobial activity of solvent extracts
of  Girardenia  diversifolia  solvent  was  studied  and  reported  to  have
antimicrobial activity against bacterial infection caused by E.coli and against
fungal disease, caused by Aspegillus Niger. 
2) S.B. Mada et al.,  have studied the hepatoprotective activity of  Mormodica
charntia leaves extract against carbon tetrachloride induced hepatotoxicity in
rats and reported that the hepatoprotective activity of extract of leaves may be
attributed to the antioxidant property of the plant. 
3) M.  Pushpalatha  and  T.  Ananthi,  reported  that  the  ethanolic  extract  of
Solanum pubescens showed hepatoprotective and antioxidant potential against
carbon  tetrachloride  induced  hepatotoxicity  in  Albino  rats  by  judging  the
serum marker enzymes and antioxidant levels in liver tissues. 
4) HaiZhongHuo  et  al.,  have  studied  the  hepatoprotective  and  antioxidant
effects  of  Licorice  extract  and  reported  that  it  has  showed  remarkable
hepatoprotective and antioxidant effect  against  carbon tetrachloride induced
oxidative damage in Rats. 
5) NishaTripathi et al., reported that the phytochemical studies from the roots of
Girardinia heterohylla proved the presence of γ - sitosterol in its roots.  The γ -
sitosterol  is  reported  to  have  antihyperglycemic  effect  in  STZ  –  induced
diabetes in Rats. 
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RESEARCH ENVISAGED
AIM OF PRESENT STUDY
In  recent  year  there  has  been  a tremendous increase in  demand for  herbal
drugs due  to  its  safety,  efficacy and  better  therapeutic  results  and  also due  to  its
economic pricing as compared to synthetic or allopathic drugs, which have several
therapeutic complications. Looking to the scope of herbal  drugs and increasing its
demand especially in disease of liver, hypertension, diabetes, cancer, arthritis and skin
disease  etc,  it  was  planned  to  study  Girardinia  zeylanica  Dcne  in  detail  due  its
effectiveness for liver problems, especially for jaundice. 
Girardinia zeylanica Dcne, selected for study was made on the basis of its, 
 Folklore claiming its therapeutic use as liver protection and for jaundice.
 Degree of research work which is not done.
Very less pharmacological  studies  have been carried out on the  Girardinia
zeylanica  Dcne.  Hence,  we  have  decided  to  submit  the  project  on  Girardinia
zeylanica  Dcne  which  includes  detailed  Pharmacognostical,  Preliminary
Phytochemical  and  Pharmacological  (Acute  oral  toxicity  study,  Hepatoprotective
activity with antioxidant effect) studies to provide scientific validation to its folklore
claims.
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PLAN OF WORK
The plan of work for the study of Girardinia zeylanica Dcne was carried out
as follow.
1. Collection and authentication of plant material.
2. Pharmacognostical studies    
a) Ash value
b) Extractive value
c) Loss on drying
           3. Preliminary Phytochemical studies 
a) Preparation of extract
b) Qualitative phytochemical studies
            4. Pharmacological studies 
a) Screening of Hepatoprotective activity,
• Assessment of Liver Function Tests.
• Assessment of Antioxidant parameters.
• Histopathology of liver.
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COLLECTION AND IDENTIFICATION
COLLECTION OF SPECIMEN
The species for the proposed study that is leaves of Girardinia zeylanica Dcne
were collected carefully from National park of Mathikettan, Idukki district, Kerala. 
TAXONOMICAL IDENTIFICATION:  
The plant was collected from National park of Mathikettan, Idukki district of
kerala. The plant was positively identified by Dr. JomyAugustine, M.sc, M.Ed., PhD,
Professor and Head of the Department of Botany St.Thomas College, Pala, Kottayam
and authenticated the plant as  Girardenia zeylanica Dcne of family Urticaceae from
available literature.
TREATMENT OF PLANT MATERIAL:
The leaves of Girardenia zeylanica Dcne were washed thoroughly with water
to remove the mud or dust, then it was shade dried completely. The dried leaves of
Girardenia zeylanica  Dcne was then powdered by means of mixer grinder and was
sieved through sieve  no.60 to  get  the  coarse powder,  which was used  for  further
detailed studies, extraction with solvent and phytochemical studies.
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BOTANICAL INFORMATION
GENERAL INFORMATION:
Common name - Nilgiri Nettle, Himalayan Giant Nettle
Binomial name - Girardenia zeylanica Dcne
Family - Urticaceae
TAXONOMICAL CLASSIFICATION
Kingdom - Plantae
Division - Magnoliophyta
Class - Magnoliatae
Order - Urticales
Family - Urticaceae
Genus - Girardinia
Species - G. zeylanica 
VERNACULAR NAMES:
Common name - Himalayan Giant Nettle, Nilgiri Nettle
Malayalam - Anachoriyanam, Kuttithoova
Tamil - Chenthotti
Hindi - Bichua, Alla, Awa
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Geographical source:
Girardenia zeylanica Dcne is found abundantly in open forest land and river
side of moist habitat in Himalayan parts of India like Uttarakhand, Himachal Pradesh
and J&K and in high altitudes of Western Ghats and in Nepal.  It  grows naturally
within elevations of 1,200 to 3,000 metres (3,900 to 9,800 feet). It is a shade bearing,
tall, stout and erect herb growing up to 3m height with perennial roots stock. The
plant is found on clump and each clump has many stem. The stem bark contains fibers
of unique quality which is strong, smooth and light.
Description:
A tall  robust,  perennial-rooted  herb,  1.2-1.3  m.  high,  closely  armed  with
slender stinging hairs, stem and branches furrowed. Leaves alternate, 3-nerved, entire
or  lobed,  serrate;  stipules  connate,  foliaceous.  Flowers  monoecious,  in  simple  or
panicled cymes or heads armed with stinging hairs. Perianth simple. 
Leaves 10-25 cm. long and often as broad, the upper variously lobed and more
or less deeply cut though never to the base, more or less - pubescent, coarsely serrate,
the serratures triangular, sometimes 13 mm. deep, petioles 7.5-18 cm. long, armed
with stinging hairs; stipules 13-16 by 8 mm., ovate, cordate, shortly acuminate, 2-fid.
Flowfers in pedunculateracemose cymes, the males in the lower, the females in the
upper axils. (C.P. Khare, 2007).
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Photographs of Girardenia zeylanica Dcne  
Fig. 4 
Fig. 5 – Stinging hairs of G. zeylanica leaves
Chemical constituents: 
Girardenia  zeylanica  Dcne  contain  alkaloids,  glycosides,  flavonoids  and
steroids.  An analysis of  leaves and stems revealed the following: moisture 72.5%,
protein 1.4%, fat 0.3%, carbohydrate 2.6%, fibers 20.9%, ash 1.8%, calcium 0.2%,
phosphorus 0.06%. Leaves are rich in vitamin C and A, and also contain vitamin B.
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The  ash  is  rich  in  sulfate  and  potassium  chloride.  Stigmasta-4,22-dien-3-one,
stigmasterol,  stigmasteryl  stearate,  and  palmitic  acids  are  reported  in  Girardinia
zeylanica  Dcne  Plant  gave  2-di-C-glcosylflavones  of  vicenin  and  lucenin  type,
anthocyanin-cynidin-3-glucoside, luteolin-7-glycoside and mono-C-glcosyl flavones –
vitexin and orientin.
Medicinal uses: 
The plant is considered antitubercular, antiseptic and antidysentric. In Rwanda
Girardenia zeylanica Dcne is part of an antidote against snakebites, and in veterinary
medicine a maceration of the leaves is used for treatment of theileriasis. In Kenya the
root is  boiled in goat’s bone soup, which is  drunk to gain strength.  In  Nepal leaf
preparations are used for the treatment of headache, fever and swollen joints, and
juice of the root is given in case of constipation. Ash of the plant is applied externally
for the treatment of ringworm and eczema. In north-eastern India the seeds are used as
fishpoison.
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MATERIALS AND METHODS
PHARMACOGNOSTICAL STUDIES:
Ash values, extractive value, loss on drying are used for the study of physical
properties.
ANALYTICAL PARAMETERS
 ASH VALUES
Ash values are helpful in determining the quality and purity of crude drug,
especially in the powdered form.  
The ash content of a crude drug is generally taken to be the residue remaining
after incineration. Ash standards have been established for a number of official drugs.
Usually these standards get a maximum limit on the total ash or on the acid insoluble
ash permitted.
The total ash is the residue remaining after incineration. The acid insoluble ash
is the part of the total ash which is insoluble in diluted hydrochloric acid.
The ash or residue yielded by an organic chemical compound is as a rule, a
measure of the amount of inorganic matters present as impurity. In most cases, the
inorganic matter  is  present  in  small  amounts  which are difficult  to  remove in  the
purification process and which are not objectionable if only traces are present. Ash
values are helpful in determining the quality and purity of the crude drugs in powder
form.
Procedures  given  in  Indian  pharmacopoeia  were  used  to  determine  the
different ash values such as total ash and acid insoluble ash.
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Determination of total ash value:
Weighed accurately about 3 gm of air dried powdered drug was taken in a
tarred silica crucible and incinerated by gradually increasing the temperature to make
it  dull  red  until  free  from carbon.  Cooled  and  weighted  and  then  calculated  the
percentage of total ash with reference to the air dried drug.
 Determination of acid insoluble ash value:
The ash obtained as directed under total ash above was boiled with 25 ml of
2N HCl for 5 minutes.  The insoluble matter was collected on ashless filter paper,
washed with hot water ignited and weighed, then calculated the percentage of acid
insoluble ash with reference to the air dried drug.
 Determination of Water soluble ash value:
The total  ash obtained was boiled with 25 ml of water for 5 minutes.  The
insoluble matter was collected on an ash less filter paper, washed with hot water and
ignited for 15 minutes at a temperature not exceeding 450˚C. The weight of insoluble
matter  was  subtracted  from  the  weight  of  total  ash.  The  difference  in  weight
represents the water soluble ash. The percentage of water soluble ash calculated with
reference to the air dried drug.
Determination of sulphated ash value:
About 3 gms of accurately weighed air dried powdered drug was taken in a
tared silica crucible which was previously ignited and weighed. Then ignite gently at
first until the drug was thoroughly charred. The crucible was cooled and residue was
moistened with 1  ml of  concentrated sulphuric acid,  heated gently until  the white
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fumes were no longer evolved and ignited at 800 ±  25º C until the black particles has
disappeared. The crucible was allowed to cool, few drops of sulphuric acid was added
and again heated. The ignition was carried out as before, allowed cooling and weighed
to  get  a  constant  weight.  The  percentage  of  sulphated  ash  was  calculated  with
reference to the air dried drug. All the ash values were calculated and recorded.
 EXTRACTIVE VALUES
Extractive values  of  crude  drugs  are  useful  for  their  evaluation,  especially
when the constituents of  a  drug cannot  be readily estimated by any other  means.
Further, these values indicate the nature of the constituents present in a crude drug.
Determination of alcohol soluble extractive value
5  gm  of  the  air-dried  coarse  powder  of  Girardenia  zeylanica  Dcne was
macerated  with  100  ml  of  90% ethanol  in  a  closed  flask  for  24  hours,  shaking
frequently during the first 6 hours and allowing standing for 18hours. Thereafter, it
was filtered rapidly taking precautions against  the loss of  the solvent.  Out of that
filtrate,  25 ml  of  the  filtrate  was evaporated to  dryness  in  a  tarred  flat  bottomed
shallow  dish,  dried  at  105˚C  and  weighed.  The  percentage  of  ethanol  soluble
extractive value was calculated with reference to the air- dried drug. The results are
recorded in the table.
Determination of water soluble extractive value
Weigh accurately 5 gm of coarsely powdered drug and macerate it with 100 ml
of chloroform water in a closed flask for 24 hours, shaking frequently during the first
6 hours and allow to standing for 18 hours. Thereafter, it was filtered rapidly taking
precautions against loss of the solvent. Then 25 ml of the filtrate was evaporated to
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dryness  in  a  tarred  flat  bottomed shallow dish,  dried  at  105˚C and  weighed.  The
percentage of water soluble extractive was calculated with reference to the air dried
drug. The results are given in the table.
 LOSS ON DRYING
Loss on drying is the loss in weight in percentage w/w determined by means
of the procedure given below. It determines the amount of volatile matter of any kind
(including water) that can be driven off under the condition specified (Desiccators or
hot air oven). If the sample is in the form of large crystals, then reduce the size by
quick crushing to a powder.
Procedure
About 1.5 gm of powdered drug was weighed accurately in a tarred porcelain
dish which was previously dried at 105˚C in hot air oven to constant weight and then
weighed. From the difference in weight, the percentage loss of drying with reference
to the air dried substance was calculated. 
PRELIMINARY PHYTOCHEMICAL ANALYSIS
Extraction of leaf of Girardenia zeylanica Dcne :
About 250 gm of air dried powdered material was taken in 1000ml soxhlet
apparatus and extracted with petroleum ether for 2 days to remove fatty substances. At
the end of 2nd day the powder was taken out and it was dried. After drying it was again
packed and extracted by using ethanol as solvent, till colour disappeared. After that
extract was concentrated by distillation and solvent was recovered. The final solution
was evaporated to dryness. 
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S.No. Name of extract Colour Consistency Yield% W/W
1 Ethanolic extract Dark greenish Sticky mass 12.5
Table: 1. Nature and colour of ethanol extract of Girardenia zeylanica Dcne.
CHEMICAL TESTS:
A) Test for carbohydrates
1. Molisch  Test: It  consists  of  treating  the  compounds  with  -naphthol  and
concentrated sulphuric acid along the sides of the test tube. 
Purple colour or reddish violet colour was produced at the junction between
two liquids. (Kokate, C.K et al, 2000)
2. Fehling’s Test: Equal quantity of Fehling’s solution A and B is added. Heat
gently, brick red precipitate is obtained.
3. Benedict’s  test: To the 5ml of Benedict’s reagent,  add 8 drops of solution
under examination. Mix well, boiling the mixture vigorously for two minutes
and then cool. Red precipitate is obtained.
4. Barfoed’s test: To the 5ml of the Barfoed’s solution add 0.5ml of solution
under  examination,  heat  to  boiling,  formation  of  red  precipitate  of  copper
oxide is obtained.
B) Test for Alkaloids
1. Dragendroff’s Test: To the extract, add 1ml of Dragendroff’s reagent. Orange
red precipitate is produced.
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2. Wagner’s test: To the extract add Wagner reagent. Reddish brown precipitate
is produced.
3. Mayer’s Test: To the extract add 1ml or 2ml of Mayer’s reagent. Dull white
precipitate is produced.   
4. Hager’s Test: To the extract add 3ml of Hager’s reagent yellow Precipitate is
produced.
C) Test for Steroids and Sterols
1. Liebermann Burchard test: Dissolve the test sample in 2ml of chloroform in
a  dry  test  tube.  Now  add  10  drops  of  acetic  anhydride  and  2  drops  of
concentrated sulphuric acid. The solution becomes red, then blue and finally
bluish green in colour.
2. Salkowski test: Dissolve the sample of test solution in chloroform and add
equal volume of conc. sulphuric acid. Bluish red cherry red and purple color is
noted in chloroform layer, whereas acid assumes marked green fluorescence.
D) Test for Glycosides
1. Legal’s test: Sample is dissolved in pyridine; sodium nitropruside solution is
added to it and made alkaline. Pink red colour is produced.
2. Baljet test: To the drug sample, sodium picrate solution is added. Yellow to
orange colour is produced.
3. Borntrager test: Add a few ml of dilute sulphuric acid to the test solution.
Boil, filter and extract the filtrate with ether or chloroform. Then organic layer
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is separated to which ammonia is added, pink, red or violet colour is produced
in organic layer.
4. Killer Killani  test: Sample  is  dissolved  in  acetic  acid  containing trace  of
ferric chloride and transferred to the surface of concentrated sulphuric acid. At
the  junction  of  liquid  reddish  brown  color  is  produced  which  gradually
becomes blue.
E) Test for Saponins
Foam test:About 1ml of alcoholic sample is diluted separately with distilled water to
20ml, and shaken in graduated cylinder for 15 minutes.1 cm layer of foam indicates
the presence of saponins.
F) Test for Flavonoids
Shinoda test: Red colour is produced when the sample, magnesium turnings and then
concentrated hydrochloric acid is added.
G) Test for Tri-terpenoids
In the test tube, 2 or 3 granules of tin was added, and dissolved in a 2ml of
thionyl chloride solution and test solution is added. Pink colour is produced which
indicates the presence of triterpenoids.
H)Tests for Tannins and Phenolic Compounds:
The Phenol content in the raw material  of  Girardenia zeylanica  Dcne was
estimated by spectroscopically.
To 2-3 ml of extract, add few drops of following reagents: 
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a)  5% FeCl3 solution: deep blue-black color.
b)  Lead acetate solution: white precipitate.
c)  Gelatin solution: white precipitate
d)  Bromine water: decolouration of bromine water.
e)  Acetic acid solution: red color solution 
f)  Dilute iodine solution: transient red color.
g)  Dilute HNO3: reddish to yellow color.
I) Test for Fixed Oils and Fatty acids
a) Spot test:
Small  quantity of the extract  is  placed between two filter  papers. Oil stain
produced with any extract shows the presence of fixed oils and fats in the extracts.
b) Saponification test:
Few drops of 0.5N alcoholic potassium hydroxide are added to the extract
with few drops of phenolphthalein solution. Later the mixture is heated on water bath
for  1-2  hours.Soap  formation  indicates  the  presence  of  fixed  oils  and  fats  in  the
extracts.
J) Test for Gums and Mucilage:
a) Ruthenium red test:
Small quantities of extract are diluted with water and added with ruthenium
red solution. A pink colour production shows the presence of gums and mucilage.
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K) Test for Proteins and Amino acids
Biuret test: Add 1 ml of 40% sodium hydroxide and 2 drops of 1% copper sulphate to
the extract, a violet colour indicates the presence of proteins.
Ninhydrin  test: Add  2  drops  of  freshly prepared  0.2% Ninhydrin  reagent  to  the
extract and heat. A blue colour develops indicating the presence of proteins, peptides
or amino acids.
Xanthoprotein  test: To  the  extract,  add  20% of  sodium hydroxide  or  ammonia.
Orange colour indicates presence of aromatic amino acid.
TOXICOLOGICAL EVALUATION
Determination of LD50 value
Acute Oral Toxicity Study
The procedure was followed by using OECD guidelines 423 (Acute toxic class
method).
The acute toxic class method is a step wise procedure with 3 animals of single
sex per step. Depending on the mortality and / or moribund status of the animals, on
average 2-4 steps may be necessary to allow judgment on the acute toxicity of the test
animals while allowing for acceptable data based scientific conclusion.
The method uses defined doses (5, 50, 300, 2000 mg / kg body weight) and the
results allow a substance to be ranked and classified according to the OECD for the
classification of chemical which cause acute toxicity.
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Procedure:
Twelve animals (Wister Albino rats, 150-200gm) were selected for studies.The
starting dose level of Girardenia zeylanica Dcne extract was 100 mg/kg body weight
per oral.Most of the crude extracts possess LD50 value more than 2000 mg. /kg of the
body weight of animal used.
Dose volume was administered 0.1 ml / 100 gm. body weight to the animal by
oral route. After giving the dose the toxic signs were observed within 3-4 hours.
Body weight of animals before and after administration, onset of toxicity and
signs of toxicity like changes in skin and fur, eyes, and mucous membrane and also
respiratory,  circulatory,  autonomic  and  central  nervous  systems  and  somato-motor
activity  and  behavior  pattern,  signs  of  tremors,  convulsion,  salivation,  diarrhoea,
lethargy, sleep and coma was also to be noted, if any, was observed.
PHARMACOLOGICAL EVALUATION
Animals:
Healthy male Wistar albino rats of 2 to 3 months of age and approximately
weighing between 150-250g were used in  the present  study.  Rats  were housed in
polypropylene cages  and allowed free access  to  feed and tap water  under  strictly
controlled pathogen free conditions with room temperature 25±2ºC.
All the animals were followed the internationally accepted ethical guidelines
for the care of laboratory animals. The experimental protocol has been approved by
institutional  animal  ethics  committee,  JKKMMRF  College  of  Pharmacy,
B.Komarapalayam, Namakkal. (Regd. No. JKKMMRFCP/1158/PO/ac/07CPCSEA)
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EXPERIMENTAL PROTOCOL:
The rats  were divided into five groups,  comprising of  six  animals  in each
group.
Group I : Received 5% CMC 10ml/kg body weight. The group served as a 
normal control.
Group II : Received CCl4 (0.7 ml/kg) body weight intraperitonially.
Group III : Received Silymarin, the standard drug (25mg/kg).
Group IV : Received ethanolic extract of leaves of Girardenia zeylanica  
100mg/Kg.
Group V : Received ethanolic extract of leaves of Girardenia zeylanica  
200mg/Kg.
0.7 ml/kg of CCl4 was injected intra peritoneally (i.p.)  to all groups except
normal control to induce hepatotoxicity on 3, 6 and 10thdays of experiment. Duration
of the study was 10 days. All the animals were sacrificed on the 11th day  for the
estimation of biochemical parameters. 
Estimation of serum biochemical parameters:
On 11th day blood was collected from animals under anaesthesia by cardiac
puncture.  Blood samples collected was centrifuged at 3500 rpm for 15 mins at room
temperature for separation of serum. The clear, non-haemolysed sera was separated
using clean dry disposable plastic syringe and stored at -20ºC for measurements of the
following,
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Liver function test:
 Serum glutamic pyruvic transaminase (SGPT) 
 Serum glutamic oxaloacetic transaminase (SGOT) 
 Alkaline phosphatase (ALP) 
 Total protein (TP)
 Total bilirubin (TB) 
Lipid profiles:
 Cholesterol
 Triglycerides (TG)
 High Density Lipoprotein (HDL)
 Low Density Lipoprotein (LDL) and 
 Very Low Density Lipoprotein (VLDL)
EVALUATION OF SERUM PARAMETERS:
All the above biochemical  parameters were estimated using serum. All  the
above biochemical parameters were estimated using semi-auto analyzer (Photometer
5010 v5+, Germany) with enzymatic kits procured from Primal Healthcare limited, Lab
Diagnostic Division, Mumbai, India.
A) ESTIMATION OF SGPT
Serum Glutamate Pyruvate Transaminase (SGPT) 
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Principle
L-Alanine +2-oxoglutarate         ALAT                  L-Glutamate + Pyruvate 
Pyruvate + NADH + H+                                                  D-Lactate + NAD+
Addition  of  pyridoxal-5-phosphate (P-5-P)  stabilizes  the transaminases  and
avoids  falsely  low  values  in  samples  containing  insufficient  endogenous  P-5-P,
eg.from patients with myocardial infarction, liver diseases and intensive care patients.
Method
Kinetic UV test, according to the international federation of clinical chemistry
and laboratory medicine (IFCC)
Table Shows reagents of SGPT in the kit
Reagent-1 Concentratio
n
TRIS PH 7.5 100 mmol/l
L-Alanine 500 mmol/l
LDH (lactate dehydrogenase) 1200 U/l
Reagent-2 Concentratio
n
2-Oxoglutarate 15 mmol/l
NADH 0.18 mmol/l
Good's buffer PH 9.6 0.7mmol/l
Pyridoxal -5-Phosphate 0.09 mmol/l
Assay Procedure
Mix 800 µl of reagent-1 with 200 µl of reagent-2 in a 5 ml test tube
a) To this, added 100 µlof serum.
b) Mixed well and took the reading immediately. Normal range: <41 u/l
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B) ESTIMATION OF SGOT
Serum Glutamate Oxaloacetate Transaminase (SGOT) 
Principle
Alanine aminotransferase (ALAT) and aspartate amino transferase (ASAT) are
the most  important  group  of  enzymes  of  aminotransferase.  These enzymes  act  as
catalyst in conversion of a -keto acids in to amino acids by transfer of amino groups.
Increased levels of ALAT is found in the hepatobiliary disease condition where
as increased ASAT levels occur in damaged conditions of heart and skeletal muscles
as well as liver parenchyma. Parallel measurement of ALAT and ASAT is therefore
applied to distinguish liver from heart or skeletal muscle damages
The ASAT/ALAT ratio is used from differential diagnosis of liver diseases 
L-Aspartate + 2-Oxaloglutarate          ASAT         L-Glutamate + oxaloacetate        
Oxaloacetate + NADH + H+          MDH     D-  Malate + NAD+ 
Method
Optimized UV- test according to IFCC (International Federation of Clinical
Chemistry and Laboratory Medicine)
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Table shows Reagents of SGOT in the kit
Reagent-1 Concentration
TRIS Ph 7.8 80 mmol/l
L- Aspartate 240 mmol/l
MDH(malate dehydrogenase) 600 U/l
LDH(lactate dehydrogenase) 600 U/l
Reagent-2 Concentration
2-Oxaloglutarate 12 mmol
NADH 0.18 mmol
Good buffer pH 9.6 0.7 mmol/l
Pyridoxal-5-Phosphate 0.09 mmol/l
Assay procedure
a. Mixed 800 µl of reagent-1 with 200 µl of reagent-2 in a 5 ml test tube
b. To this, added 100 µl of serum
c. Mixed well and took the reading immediately
Normal range : <37u/l
C) ESTIMATION OF ALKALINE PHOSPHATASE 
Principle
Alkaline phosphatase (ALP), hydrolytic enzyme acting optimally at alkaline
pH, exists in blood in numerous distinct forms which originate mainly from bone and
liver.
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p-Nitro phenyl phosphate + water          ALP          Phosphate + p-Nitro phenol 
Method
Kinetic photometric test, according to the international Federation of clinical
chemistry and laboratory Medicine (IFCC).
Table Shows reagents of alkaline phosphatase in the kit
Reagent 1 Concentration
2-Amino-2-methyl-1-propanol pH 10.4 0.35 mol/l
Magnesium sulphate 2.0 mmol/l
Zinc sulphate 1.0 mmol/l
HEDTA 2.0 mmol/l
Reagent 2 Concentration
p-Nitrophenylphosphate 16.0 mmol/l
Test Procedure
Take 1000 µl of reagent-1 in a 5 ml test tube.
To this add 250pl of reagent-2 and mix well.
Add 20 µl of serum and mix well and take reading immediately and read absorbance
at 405nm.
Normal range: 53-128 u/l.
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D) ESTIMATION OF TOTAL PROTEIN 
Principle
Protein forms a coloured complex with cupric ions in alkaline medium. 
Table Shows reagents of total protein in the kit
Reagent-1 Concentration
Cupric sulphate 6 mmol/l
Potassium iodide 15 mmol/l
Reagent-2 Concentration
Protein (std) 6 g/100ml
Method: Biuret method 
Procedure:
Preparation of test sample.
Take l ml of reagent-1 in a 5 ml test tube.
To this add 0.02 ml of serum.
Mix well  and incubate at  a room temperature for 15 min and read the test
sample at 750 nm.Normal range: 3.2 to 4.2 g/dl.
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LIPID PROFILES
A. ESTIMATION OF CHOLESTEROL 
     Cholesterol was estimated by the following method.
Reagent Concentration
Ferric chloride-acetic acid 
reagent 0.05%
Cholesterol stock standard 1 mg/ml in acetic acid
Cholesterol working standard 40 ag in ferric chloride-acetic acid 
reagent
Concentrated sulfuric acid. 3.0 ml
Procedure
0.1 ml of extract was evaporated to dryness and 5.0 ml ferric chloride- acetic
acid  reagent  was  added,  mixed  and  centrifuged.  To  the  supernatant  3.0  ml  of
concentrated sulfuric acid was added and the absorbance was read after 20 min at 560
nm against a reagent blank. A Standard in the concentration range of 40-200 µg was
treated similarly.
Values were expressed as mg/dL serum.
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B. DETERMINATION OF TRIGLYCERIDES
Triglycerides were determined by the following method.
Triglycerides  are extracted by isopropanol,  which upon saponification with
potassium hydroxide yield glycerol and soap.  The glycerol liberated is treated with
meta  per  iodate,  which  releases  formaldehyde,  formic  acid  and  iodide.   The
formaldehyde  released  reacts  with  acetyl  acetone  and  ammonia  forming  yellow
coloured compound, the intensity of which is measured at 420nm.
Reagent Concentration
Saponification reagent 0.6 ml
Sodium meta per iodate reagent 650 mg.
Acetyl acetone reagent 0.5 ml
Standard triolein solution 1 g of triolein was dissolvedin 100 ml isopropanol
Reagents:
1. Isopropanol.
2. Activated aluminium oxide (Neutral).
3. Saponification reagent – 5 g of potassium hydroxide was dissolved in 60 ml of
distilled water and 40 ml of isopropanol was added to it.
4. Sodium meta per iodate reagent - 77 g of anhydrous ammonium acetate was
dissolved in about 700 ml of distilled water,  60 ml glacial  acetic acid was
added to it followed by 650 mg of sodium meta periodate.  The mixture was
diluted to 1 litre with distilled water.
Dept. of Pharmacology 67 JKKMMRF College of Pharmacy
Chapter 7 Materials and Methods
5. Acetyl acetone reagent - 0.75 ml of acetyl acetone was dissolved in 60 ml of
distilled water and 40 ml of isopropanol was added to it.
6. Standard triolein solution - 1 g of triolein was dissolved in 100 ml isopropanol.
1 ml of stock standard was diluted to 100 ml to prepare a working standard
100 µg of triolein/ml.
Procedure
An aliquot of serum/lipid extract was evaporated to dryness.  0.1 ml of ethanol
was added followed by 4 ml of isopropanol.  0.4 g of alumina was added to all the
tubes and shaken well for 15 min.  Centrifuged and then 2 ml of the supernatant was
transferred to labeled tubes.  The tubes were placed in a water bath at 65µC for 15
min for saponification after adding 0.6 ml of the saponification reagent followed by
0.5 ml of acetyl acetone reagent.  After mixing, the tubes were kept in a water bath at
65°C for 1 h, the contents were cooled and absorbance was read at 420nm. A series of
standards of concentrations 8-40 °g triolein were treated similarly along with a blank
containing only the reagents.  All the tubes were cooled and read at 420nm.
The triglyceride content was expressed as mg/dL serum. 
C. ESTIMATION OF HDL-CHOLESTEROL
Principle
The common classification of lipoproteins  – HDL, LDL and VLDL comes
mainly from ultra centrifugation of serum or plasma.  HDL (specific gravity more
than 1.063) can be separated by using polyionic substances along with bivalent metal
ions.   HDL  is  separated  from  other  protein  fractions  by  treating  serum  with
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phosphotungstic  acid and magnesium chloride.  HDL remains in  solution while all
other  lipoprotein  fractions  are  precipitated.   Centrifugation  separates  high  density
lipoproteins  as  a  clear  supernatant.  Cholesterol  content  of  which  is  estimated  by
enzymatic method as described earlier in estimation of total cholesterol.
Reagents
1. Enzyme reagent
2. Diluent buffer
3. Precipitating reagent PEG-6000
4. Standard – 200 mg/dL
The working reagent is prepared by dissolving enzyme reagent with 25ml of
diluent buffer and kept for at least 10 min before use.  The working reagent is stable
for 4 weeks at 2-80C.
Procedure
0.5 ml of serum was taken into a glass tube and added 0.05 ml of precipitating
reagent. Mixed well, and kept at room temperature for 10 min. The mixture was then
centrifuged for 15 min at 4000 rpm. Separated the clear supernatant and immediately
determined cholesterol content.
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D. ESTIMATION OF LDL-CHOLESTEROL AND VLDL-CHOLESTEROL
The amounts of LDL-cholesterol and VLDL-cholesterol  were calculated by
using the Friedwald formula.
VLDL-Cholesterol = Triglycerides / 5
LDL-Cholesterol    = Total-Cholesterol – (HDL + VLDL)
The levels of HDL, LDL and VLDL-cholesterol are expressed as mg/dL
Estimation of antioxidant parameters
On 11th day animals were sacrificed after blood withdrawal and abdomen was
cut open and liver was dissected out.
The liver was perfused with 0.86% cold saline to completely remove all the
red blood cells. Then it was suspended in 10% (w/v) ice-cold 0.1 M phosphate buffer
(pH  7.4)  Cut  into  small  pieces,  and  the  required  quantity  was  weighed  and
homogenized using a homogenizer. The homogenate was centrifuged at 3000 rpm for
20 min to remove the cell  debris.  The supernatant  was used for the estimation of
Catalase, Superoxide dismutase, Glutathione peroxidase and Lipid peroxidase.
INVIVO ANTIOXIDANT ENZYME ESTIMATION
The homogenate was centrifuged and supernatant was used for the assay of
marker enzymes namely,
Catalase (CAT)
Superoxide dismutase (SOD)
Lipid peroxidase (LPOX)
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1. ESTIMATION OF CATALASE (CAT) ACTIVITY 
Reagents:
Dichromate/acetic acid reagent (5% solution of potassium dichromate in  acetic
acid at 1:3 ratios)
0.01 M Phosphate buffer, pH 7.0
0.2 M Hydrogen peroxide
Procedure
Catalase(CAT)  was  estimated  by  the  method  of  Sinha  (1972).The  reaction
mixture (1.5ml vol) contained 1.0 ml of 0.01 M phosphate buffer (Ph7.0) 0.1 ml of
tissue homogenate and 0.4 ml of 2M  H
２
O
２
.  The reaction was stopped by the
addition  of  2.0  ml  dichromate-acetic  acid  reagent  (5% potassium dichromate  and
glacial acetic acid were mixed in 1:3 ratio).Then the absorbance was measured at 530
nm. 
2. ESTIMATION OF SUPEROXIDE DISMUTASE (SOD) ACTIVITY
Reagents
1. Adrenaline
2. Carbonate buffer (pH 10.2)
3. Mm EDTA
Procedure
The activity of superoxide dismutase (SOD) was assayed by the method of
Kakkar  et  al  based  on  the  oxidation  of  epinephrine  adrenochrome  transition  by
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enzyme. The post-mitochondrial suspension of mice liver (0.5ml) was diluted with
distilled water  (0.5).To this chilled ethanol (0.25ml)  and chloroform (0.15ml) was
added. The mixture was shaken for 1 min and centrifuged at 2000 × g for 10 min.The
PMS (0.5ml) was added with PBS buffer (Ph 7.2; 1.5ml).The reaction initiated by the
addition  of  epinephrine(0.4ml)  and  change  in  optical  density  (O.D.,min-l)  was
measured at  470 nm.SOD activity was expressed as U/l  of tissue.  Change in O.D
(min-1) at 50% inhibition to adrenochrome transition by the enzyme was taken as one
enzyme unit.
3. ESTIMATION OF LIPID PEROXIDASE OF RAT LIVER
Reagents
1. Thiobarbituric acid 0.37%
2. 0.25N HC1
3. 15% TCA
 Procedure
Lipid  peroxidase  in  liver  was  estimated  calorimetrically  by  measuring
thiobarbituric  acid  reactive substances  (TBARS) using the method of  Fraga  et  al.
(1988).  In  brief,  0.l  ml  of  tissue  homogenate  was  treated  with  2  ml  of  TBA-
trichloroacetic acid -HC1 reagent (0.37% TBA, 0.25 M HC1 and 15% TCA, 1:1:1
ratio), placed for 15 min in a water bath and then cooled and centrifuged at 3500 × g
for 10 min at room temperature, the absorbance of clear supernatant was measured at
535 nm against a reference blank. Values were observed.
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HISTOPATHOLOGICAL INVESTIGATIONS
A portion of liver processed for histopathological investigations.
Histopathological techniques
Histopathology  is  the  microscopical  study  of  tissues  for  pathological
alterations.  This  involves  collection  of  morbid  tissues  from  biopsy  or  necropsy,
fixation, preparation of sections, staining and microscopical examination.
Collection of materials
Thin pieces of 3 to 5 mm, thickness are collected from tissues showing gross
morbid changes along with normal tissue.
Fixation
Keeping the tissue in fixative for 24-48 hours at room temperature
1. Serves to harden the tissues by coagulating the cell protein,
2. Prevents autolysis.  
3. Preserves the structure of the tissue, and
4. Prevents shrinkage: The volume of the fixative added is 10 times the volume of
the tissues. Common Fixatives: 10% Formalin
Haematoxylin and eosin method of staining
Deparaffinise  the  section  by  xylol  5  to  10  minutes  and  remove  xylol  by
absolute alcohol, then wash in tap water. Stain with haematoxylin for 3-4 minutes and
wash in tap water. Allow the sections in tap water 5-10 min and wash in tap water.
Counter stain with 0.5% eosin until section appears light pink (15 to 30seconds), and
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then wash in tap water. Blot and dehydrate in alcohol. Clear with xylol (15 to 30
seconds). Mount in Canada balsam or DPX Moutant. Keep slide dry and remove air
bubbles.
STATISTICAL ANALYSIS
All  the  values  of  biochemical  and  antioxidant  parameter  estimations  were
expressed  as  mean  ±  standard  error  of  mean  (S.E.M)  and  was  analyzed  for
significance  by  ANOVA and  groups  were  compared  by  Tukey-Kramer  multiple
comparison  test,  using  InStat  v.2.02  and  prism  v.5  software  (GraphPad  Software
Inc.).Differences between groups (p Value) were considered significant at P<0.05.
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RESULTS AND DISCUSSION
The plant,  Girardenia  zeylanica  Dcne belonging to  family Urticaceae  was
selected for my project, on the basis of ethanobotanical information which reveals its
uses against one of the most hazardous disease.
Girardenia zeylanica  Dcne,  is commonly called as Himalayan Giant Nettle;
Nilgiri Nettle, is a perennial-rooted herb found abundantly in open forest land and
river side of moist habitat in Himalayan parts of India like Uttarakhand, Himachal
Pradesh and J&K and in high altitudes of Western Ghats and in Nepal.
            Literature survey revealed that not much work has been done on this plant
claiming maximum therapeutic uses. So we felt worthwhile to validate scientifically,
the  folk  claim  for  its  therapeutic  activity.  We  have  also  taken  its  detailed
Pharmacognostical  and  preliminary  phytochemical  investigations  to  prove  its
appropriate identification and rationalize its use as drug of therapeutic importance.
1. PHARMACOGNOSTICAL STUDIES
ANALYTICAL PARAMETERS
The analytical parameters were investigated and reported as, total ash value
(9.2 %w/w), water soluble ash value (3.4%w/w), loss on drying (5.11 %w/w), acid
insoluble  ash  value  (3.5  %w/w),  sulphated  ash  value  (5.1  %w/w),  water  soluble
extractive value (3.7 %w/w), alcohol soluble extractive value (4.6 %w/w),. The above
studies were enabled to identify the plant material for future investigation and form an
important aspect of drug studies. 
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The results were given in table.
1. Ash values
Table: 1. Data for ash values for powdered leaves of Girardenia zeylanica 
S.No
PARAMETER
%w/w
ASH VALUES
1. Total Ash 9.2
 2. Water Soluble Ash 3.4
3. Acid Insoluble Ash 3.5
4. Sulphated Ash 5.1
2. Extractive values and loss on drying
Table:  2.Data  for extractive values  and loss  on drying of  powdered leaves  of
Girardenia zeylanica 
Analytical parameter Percentage (w/w)
Water soluble extractive 3.7 %
Alcohol soluble extractive 4.6 %
Loss on drying 5.11 %
PRELIMINARY PHYTOCHEMICAL STUDIES
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The leaves of  Girardenia zeylanica  Dcne were subjected for hot continuous
extraction using ethanol as solvent. The yield was found to be 5.27% w/w. the extracts
obtained  were  subjected  to  various  phytochemical  tests,  to  identify  the  active
constituents,  which  showed  the  presence  of  alkaloids,  glycosides,  flavonoids,  and
steroids, carbohydrate, fatty acids and proteins and phenolic compounds. The results
were given in table: 3. 
Table:  3.  Results of  Phytochemical  analysis  of  powdered leaves  of  Girardenia
zeylanica 
PHYTOCONSTITUENTS ETHANOL   EXTRACT
Alkaloids +
Saponins -
Glycosides +
Carbohydrates +
Tannins -
Flavanoids +
Terpenoids +
Steroids +
Phenolic compounds +
Proteins and amino acids +
Fixed oils and fatty acids +
Gums and mucilage -
2. TOXICOLOGICAL STUDIES
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Acute oral toxicity studies
The acute oral toxicity of  Girardenia zeylanica Dcne extract was carried out
as per OECD 423 – guidelines (Acute toxic class method). 
No toxicity or death was observed for these given dose levels, in selected and
treated animals. Hence, the acute toxicity studies revealed that LD50> 2000mg/kg for
the extract. 
Hence, the biological dose was fixed at two dose levels, 100 and 200 mg/kg of
body weight.
3. PHARMACOLOGICAL STUDIES
EVALUATION OF HEPATOPROTECTIVE ACTIVITY
Assessment of serum biochemical parameters
Ethanol  extract  of Girardenia  zeylanica  Dcne  possessed  a  good
hepatoprotective activity on rats as shown in the table. At varying dose levels, (100
mg/kg  and  200  mg/kg),  this  extract  attenuated  altered  biochemical  parameters
produced  by  CCl4 was  dose  dependent.  This  extract  possessed  significant
hepatoprotective activity at both 100 and 200 mg/kg dose level.
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Table-4. Effect of Girardenia zeylanica Dcne extract on serum parameters in CCl4
induced hepatic damage in rats
Treatment
SGOT
(U/L) SGPT (U/L) ALP (U/L)
TOTAL
BILIRUBIN
(mg/dl)
TOTAL
PROTEIN
(mg/dl)
GROUP I
97.26
±
0.34
81.42
±
0.13
141.9 
±
0.10
0.77
±
0.003
10.04
±
 0.005
GROUP II
236.1 
±
0.20a
364.76
±
1.27 a
397.36
 ±
0.12a
2.26
±
0.006a
6.81 
±
0.009a
GROUP III
103.05
±
0.09a
106.21
±
 0.13a
165.9
±
0.10a
0.85
±
0.005 a
9.58
±
0.003a
GROUP IV 206.13
±
0.10a
210.20
±
0.30a
215.7
±
0.17a
1.71
±
0.23b
7.53 
±
0.005ns
GROUP V
115.3
 ±
0.28 a
116.33
±
0.62a
178.25
±
0.11a
0.9 
±
0.005a
8.12 
±
0.52b
Values  are  given  as  mean  ± Standard  error  mean (S.E.M) for  five  groups  of  six
animals each. Values are statistically significant at c=p<0.05, b=p<0.01, a= p<0.001.
Group II compared with group I and Groups III, IV & V were compared with  group
II.
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Figure-6
Effect of Girardenia zeylanica Dcne extract on serum parameters in CCl4 induced
hepatic damage in rats
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Figure-7.
Effect of Girardenia zeylanica Dcne extract on total protein and total bilirubin in
CCl4 induced hepatic damage in rats
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Assessment of Lipid profiles
The serum lipid profile such as total cholesterol, triglycerides, LDL & VLDL
were elevated, and this indicated deterioration in hepatic function due to the damage
caused by CCl4 administration. 
Whereas treatment of Girardenia zeylanica Dcne extract significantly declined
the effect of CCl4 induced damage and it was evidenced by the decreased level of total
cholesterol, triglycerides, LDL & VLDL and increased level of HDL in extract group. 
             Results were shown in table 5.
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Table – 5. Effect of  Girardenia zeylanica  Dcne  extract on liver lipid profiles in
CCl4 induced hepatic damage in rats
Treatment CHOLESTEROL (mg/dl)
TRIGLYCE
RIDES
(mg/dl)
HDL
(mg/dl)
LDL
(mg/dl)
VLDL
(mg/dl)
GROUP I
72.22
±
0 .25
81.47
±
0.12
40.49
±
0.15
31.92
±
0.15
13.01
±
0.12
GROUP II
124.31
±
0.34a
128.57
±
0.62a
12.27
±
0.09a
74.44
±
0.11a
37.25
±
0.13a
GROUP III
87.56
 ±
0.62a
86.58
±
0.15a
30.08
±
0.06a
44.40
±
0.06a
16.56
±
0.12a
GROUP IV
121.01
 ±
0.83b
125.24
±
0.68b
25.27
±
0.14a
47.59
±
0.15 a
20.38
±
0.10a
GROUP V
102.29
±
0.31a
104.24
±
0.79a
28.79
±
0.18a
39.28
±
0.23a
13.51
±
0.10a
Values  are  given  as  mean  ± Standard  error  mean (S.E.M) for  five  groups  of  six
animals each. Values are statistically significant at c= p<0.05, b= p<0.01,a= p<0.001.
Group II compared with group I and Groups III, IV & V were compared with group II.
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Figure-8.
Effect of Girardenia zeylanica Dcne extract on liver lipid profiles in CCl4 induced
hepatic damage in rats
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Figure-9
Effect of Girardenia zeylanica Dcne extract on HDL, LDL, VLDL in CCl4
induced hepatic damage in rats
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Assessment of antioxidant parameters
The effects of extract at two dose levels (100 and 200 mg/kg, p.o.) on liver
antioxidant enzymes in  CCl4  -induced hepatic injury are shown in Table 2. Hepatic
injury induced by CCl4 caused significant increases in liver antioxidant enzymes such
as  catalase,  superoxide  dismutase,  glutathione  peroxidase  and  lipid  peroxidase.
Administration of EEGZ at  different  dose levels shows significant dose-dependent
decreases, when compared with diseased control animals. Results were shown in table
6.
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Table – 6.Effect of Girardenia zeylanica Dcne extract on antioxidant parameters
in CCl4 induced hepatic damage in rats
Treatment
Catalase
(U/mg  protein)
Superoxide
dismutase
(U/mg protein)
Lipid peroxidase
(nmol/mg of
protein)
GROUP I 291.32±0.22 92.05±0.16 4.62   ±0.08
GROUP II 236.29±0.12a 75±0.07a 8.34±0.07a
GROUP III 286.94±0.04a 88.01±0.13a 5.72±0.08a
GROUP IV 239.17±0.12b 76.17±0.32b 7.73±0.21b
GROUP V 277.30±0.25a 85.34±0.24a 06.55±0.07a
Values  are  given  as  mean  ± Standard  error  mean (S.E.M) for  five  groups  of  six
animals each. Values are statistically significant at c=p<0.05, b=p<0.01,a=p<0.001.
Group II compared with group I and Groups III, IV & V were compared with group II.
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Figure-10
Effect of Girardenia zeylanica Dcne extract on Catalase and SOD in CCl4 induced
hepaticdamage in rats
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Figure-11
Effect of  Girardenia zeylanica  Dcne  extract on LPOx in  CCl4 induced hepatic
damage in rats.
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Group I
10x Liver with normal lobular 40x Normal portal tract and hepatocytes
architecture
Group II
10x Liver showing parenchyma with 40x Perivenular region showing
fatty change(++++) fatty change and lobular 
and lobular inflammation inflammation
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Group III
10x Liver showing parenchyma 40x Perivenular region
with fatty change(+)
Group  IV
10x Liver showing parenchyma 40x Perivenular region showing
with fatty change (+++) fatty change(+++) 
and lobular inflammation and inflammtion
Dept. of Pharmacology 91 JKKMMRF College of Pharmacy
Chapter 8 Results and Discussion
Group  V
10x Liver showing parenchyma 40x Perivenular region showing
with fatty change(+) fatty change(+)
Figure-12.  
HISTOPATHOLOGY OF LIVER OF RAT
Photomicrograph  of  liver  shows  a  normal  hepatic  cellular  arrangements  in
Group 1 (a) whereas, in group II (b) showing loss of hepatic architecture with intense
peripheral  central  vein  necrosis,  fatty  changes,  crowding  of  central  vein.  In  rats
treated with silymarin (c), a normal hepatic architecture with moderate mild degree of
necrosis.  Group IV and group V (d & e) reduces the hepatic injury score of fatty
degeneration and necrosis, clearly indicating the protection offered by EEGZ.
DESCRIPTION OF HISTOPATHOLOGICAL EXAMINATION
Group -I 
Group I  rat  Liver tissue section shows normal lobular architecture of liver
cells.  Hepatocytes, hepatic sinusoids, portal tract, show normal size & Shape. The
central vein and sinusoids are normal. There are no inflammation fatty change.
Dept. of Pharmacology 92 JKKMMRF College of Pharmacy
Chapter 8 Results and Discussion
Group - II 
Group  II  rat  Liver  tissue  section  shows  extreme  degeneration  of  hepatic
architecture by necrosis, foci of hemorrhage, fatty changes, crowding of vein.  The
perivenular  region  shows  extensive  fatty  changes  with  the  areas  of  lobular
inflammation with hepatocytes (fatty change++++, lobular inflammation ++ ).
Group -III 
Group  III  Liver  Tissue  section  shows  mild  degree  of  liver
necrosis.Hepatocytes  are  compact.    Hepatic  sinusoids  appear  in  normal.   The
Hepatocytes are well arranged like clusters. There is no inflammation seen. The portal
tracts are normal  (Fatty change +).
Group - IV
Group - IV Liver tissue section shows hepatocytes with fatty change. Hepatic
sinusoids appear in normal. There are areas of lobular inflammation seen along with
fatty changes  in  the  perivenular  region.  There  no  fibrosis  seen  (fatty change+++,
lobular inflammation +).
Group - V 
Group - IV Liver tissue section shows that hepatocytes were regenerative and
showed no visible changes and prominent nuclei, reduced score of necrosis and there
is no inflammation. The portal tract are normal and there is no fibrosis seen. (Fatty
change +, No lobular inflammation) Thus, confirming the safety of the extract.
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DISCUSSION
Liver injury due to carbon tetrachloride in rats was first reported in 1936 and
has been widely and successfully used by many investigators. Carbon tetrachloride is
metabolized by cytochrome P 450 in endoplasmic reticulum and mitochondria with
the  formation  of  CC13O-,  a  reactive  oxidative  free  radical,  which  initiates  lipid
peroxidation and induces liver damage.
Damage induced in liver by carbon tetrachloride is accompanied by increase in
the activity of some serum enzymes. The study of different enzyme activities such as
SGOT,  SGPT,  ALP,  TOTAL BILIRUBIN,  TOTAL PROTEIN,  CHOLESTEROL,
TRIGLYCERIDES, HDL, LDL and VLDL have been found to be of great value in the
assessment of clinical and experimental liver damage.
The liver is the largest organ in the vertebrate body, and is the major site of
xenobiotic metabolism and excretion. Liver injury can be caused by toxic chemicals,
drugs, and virus infiltration from ingestion or infection. The toxins absorbed from the
intestinal tract gain access first to the liver resulting in a variety of liver ailments.
Thus liver diseases remain one of the serious health problems. (Karan et al., 1999;
Chaterrjee,  2000)   Carbon  tetrachloride  (CCl4)  has  been  widely  used  in  animal
models to investigate chemical  toxin- induced liver damage. The most remarkable
pathological characteristics of CCl4-induced hepatotoxicity are fatty liver, cirrhosis
and  necrosis,  which  have  been  thought  to  result  from  the  formation  of  reactive
intermediates  such  as  trichloromethyl  free  radicals   metabolized  by  the  mixed
function  cytochrome  P450 in  the  endoplasmic  reticulum  (Recknagel  et  al.,  1989).
Usually,  the  extent  of  hepatic  damage  is  assessed  by  the  increased  level  of
cytoplasmic enzymes (ALT, AST and ALP), thus leads to leakage of large quantities
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of enzymes into the blood circulation. This was associated by massive centrilobular
necrosis,  ballooning  degeneration  and  cellular  infiltration  of  the  liver  (Plaa  and
Charbonneau, 1989). 
The aim of the present study was to investigate whether the extract from the
plant  Girardenia zeylanica  possesses any preventive as well as curative role against
CCl4 induced  hepatic  damages.  CCl4 induced  hepatic  injuries  are  commonly used
models for the screening of hepatoprotective drugs and the extent of hepatic damage
is  assessed  by  the  level  of  released  cytoplasmic  alkaline  phosphatase  and
transaminases in circulation. It is well documented that CCl4 is biotransformed under
the action of microsomal cytochrome‐P450 of liver to reactive metabolites. These free
radicals bind covalently to unsaturated lipid membrane, provoking a sharp increase of
lipid peroxides followed by pathological changes such as elevated levels of serum
marker enzymes like SGOT, SGPT and ALP, depletion of GSH, decreased protein
synthesis, triglyceride accumulation, increased lipid peroxidation, destruction of ca2+
homeostasis  and  finally hepatocyte damage.  This  suggests  that  CCl4 induces  liver
injury by sharing a common property of free radical mechanism.
Hepatocellular  necrosis  or  membrane  damage  leads  to  very high  levels  of
serum SGOT and SGPT released from liver to circulation. Among the two, SGPT is a
better  index  of  liver  injury,  since  SGPT  catalyses  the  conversion  of  alanine  to
pyruvate and glutamate, and released in a similar manner.
The activity of serum lipid profile such as total cholesterol, triglycerides, LDL
& VLDL were elevated, and this indicated deterioration in hepatic function due to the
damage caused by CCl4 administration. Whereas treatment of  Girardenia zeylanica
extract significantly declined the effect of CCl4 induced damage and it was evidenced
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by the decreased level of total cholesterol, triglycerides, LDL & VLDL and increased
level of HDL in Girardenia zeylanica treated group.
Necrosis or membrane damage releases the enzyme in to circulation and hence
it can be measured in serum. A high level of SGOT indicates liver damage, such as
that caused by viral hepatitis as well as cardiac infraction and muscle injury. SGPT
catalyses  the  conversion  of  alanine  to  pyruvate  and  glutamate  and  is  released  in
similar manner.  Therefore SGPT is more specific to the liver  and is  thus a  better
parameter for detecting liver injury. Elevated levels of serum enzymes are indicative
of cellular  damage and loss of functional  integrity of cell membrane in liver.  The
ability of the ethanolic extract of leaves of Girardenia zeylanica prevent the increase
in the activities of these enzymes is primary evidence indicative of hepatoprotective
activity.
IN VIVO ANTIOXIDANT ENZYMES
The body has an effective mechanism to prevent and neutralize the free radical
induced damage. This is accomplished by a set of endogenous antioxidant enzymes,
such as Catalase, Glutathione peroxidase, Superoxide dismutase and Lipid peroxidase.
Any compound,  natural  or  synthetic,  with  antioxidant  properties  might  contribute
towards the partial or total alleviation of this type of damage.
Catalase (CAT) is an enzymatic antioxidant widely distributed in all tissues
and the highest activity is found in red cells and liver. Catalase is a heme protein,
localized  in  the  peroxisomes or  the microperoxisomes.  This  enzyme catalyses  the
decomposition  of  H2O2 to  water  and  oxygen  and  thus  protecting  the  cell  from
oxidative damage by H2O2 and OH.
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Superoxide dismutase (SOD), a metallo protein is the most sensitive enzyme
index  in  liver  injury  and  one  of  the  most  important  enzyme  in  the  enzymatic
antioxidant  defence  system.  It  scavenges  the  superoxide  anion  to  form hydrogen
peroxide and oxygen, hence diminishing the toxic effect caused by this radical. In the
present study, it was observed that the ethanol extract of Girardenia zeylanica leaves,
significantly increased the SOD activity in CCl4 intoxicated rats there by diminished
CCl4 induced oxidative damage.
While SOD catalyzes the conversion of superoxide free radical to less toxic
hydrogen peroxoide, GPx catalyzes the breakdown of hydrogen peroxide into water
and oxygen and can also directly detoxify lipid peroxides generated  by ROS(Castro
andFreeman,2001).  As  SOD  and  GPx  are  easily  inactivated  by  ROS  or  lipid
peroxides, this may explain a decrease in activities of these two enzymes observed in
liver tissue of CCl4 intoxicated  mice in our study. However, our results demonstrated
that SOD and GPx were appreciably elevated by EEGZ administration, suggesting
that it can restore both enzymes and/or activate enzyme activities in CCl4-damaged
liver tissue.
Lipid peroxidation has been postulated as being the destructive process in liver
injury  due  to  CCl4 administration.  Treatment  with  ethanol  extract  of Girardenia
zeylanica  leaves exhibited a significant inhibitory role against lipid peroxidation in
rats and there by diminished CCl4 induced hepatic membrane destruction and hepatic
damage. The prevention of lipid peroxidation might, at least in part, be derived from
the capability of Girardenia zeylanica leaves to scavange ROS.
The qualitative phytochemical analysis on the  ethanolic extract of Girardenia
zeylanica shows the presence of flavonoids. (C Pan Et.al, 2011). 
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The  dominant  constituents  of  Girardenia  zeylanica  are  the  flavonoids  and
triterpenoids.  Flavonoid constituent of plant possess antioxidant and hepatoprotective
properties (Wegner T and Fintelmann V, 1999). 
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SUMMARY AND CONCLUSION
The  present  study  was  undertaken  to  determine  the  hepatoprotective  and
antioxidant effect of ethanolic extract from leaf of Girardenia zeylanica Dcne.
The toxicity studies shows that the extract is not producing any harmful toxic
effects within the dose range 2000 mg/kg.
The Pharmacognostical studies made on the powdered leaves of  Girardenia
zeylanica  like ash values, extractive value, loss on drying gave valuable information.
This will help for correct identification of the plant.
The  preliminary  phytochemical  investigation  showed  the  presence  of,
alkaloids, glycosides, flavonoids, and steroids, carbohydrate, fatty acids and proteins
and phenolic compounds in ethanol extract.
Histopathological studies on isolated liver revealed that ethanolic extract  of
Girardenia zeylanica reversed the liver damage caused by CCl4. The normal pattern
of histology of liver was observed.
Phytochemical screening revealed the presence of flavonoids. Flavonoids have
been documented to possess potent antioxidant and free radical  scavenging effect.
Example: Girardenia zeylanica contain 2-di-C-glcosylflavones of vicenin and lucenin
type,  anthocyanin-cynidin-3-glucoside,  luteolin-7-glycoside  and  mono-C-glcosyl
flavones – vitexin and orientin.
Based on the results  obtained from the present  study,  it  can  be concluded
ethanolic extract of  Girardenia zeylanica is found to be more potent and effective
hepatoprotective and antioxidant activity.
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